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Abstract 
 
Aaron Jamal Young:  The Development of a Novel Series of Cationic Porphyrins 
as Disinfectants for Use in Public Health. 
(Under the direction of Dr. Louise M. Ball) 
 
  In the United States, alone, an estimated 4 million to 33 million cases of 
gastrointestinal illness resulting from contaminated water supplies occur 
annually. There is a need for the exploration of new types of disinfectants for 
water treatment with different mechanisms of action that can be used along with 
or in place of currently used disinfectants to further improve modern drinking 
water treatment.   
Photodynamic inactivation (PDI) of pathogens is a unique approach to 
water treatment.  In general, PDI consists of a chromophore that absorbs energy 
from light, and ultimately uses that energy to inactivate pathogens via singlet 
oxygen. Cationic porphyrins are one group of chromophores that have proven to 
be effective in the inactivation of viral, bacterial, fungal and parasitic pathogens.  
It is believed that the positive charge on cationic photosensitizers (PS) help them 
to better associate with the predominantly negatively charged surfaces on 
pathogens most resistant to chemical disinfection.   
The cationic porphyrins used in previous tests have carried fixed positive 
charges on the periphery of the tetrapyrrole macrocycle.  Porphyrins that carry 
positive charges connected farther from the ring through an aliphatic carbon 
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chain have been synthesized and characterized using proton nuclear magnetic 
resonance (1 H NMR), mass spectrometry (MS), and UV-Visible spectrometry 
(UV/Vis). The hypothesis was that this would allow for the positive charge to 
move more freely and possibly better adapt to the shape and negative charge 
distribution on the surface of target microorganisms. Using literature-based 
isolation techniques and the double layer enumeration method, the new cation 
location was observed to increase the porphyrins’ binding to, and subsequent 
inactivation of E. coli and Salmonella.  Viral binding was not as well correlated to 
inactivation as that of bacteria.  This novel group of porphyrins is also marked by 
a decrease in the compound’s stability as well as its toxicity in the absence of 
light. This method of increasing cation flexibility, in theory, could be used to 
increase the efficiency of PDI of bacteria for other synthetic chromophores. 
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Chapter 1: Introduction 
Review of Literature 
After 100 years, disinfection remains a cornerstone of modern water 
treatment.  Although current water treatments, such as chlorine, are relatively 
effective, there are still some inadequacies.  In the United States alone, an 
estimated 4 million to 33 million cases of gastrointestinal illness resulting from 
contaminated water supplies occur annually 1,2.  New challenges, such as 
biological contamination of water sources, an aging water distribution system, 
and increasing water reuse will require us to remain vigilant in protecting all 
aspects of our water supply.  Many pathogens, such as various parasites, gram-
negative bacteria, and non-enveloped viruses, have proven to be resistant to 
currently used disinfectants for water treatment.  This along with any additional 
biological contamination from surface runoff, flooding, and/or the increase in 
water reuse, could lead to both temporary and perpetual inadequacies in drinking 
water treatment3.  
Scientific breakthroughs and improvements in water safety regulations are 
needed to ensure that communities continue to receive safe drinking water.  
There is a need to explore new types of disinfectants for water treatment with 
different mechanisms of action that can be used along with or in place of 
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currently used disinfectants to further improve water quality in developed 
countries.    
This belief is strongly supported by the U.S. Centers for Disease Control 
and Prevention (CDC)4.  One of the CDC’s major goals is that people be 
prepared for emerging health threats.  Their literature states the following: 
 [one CDC goal is to] “Support and strengthen human and technological 
epidemiologic resources to prevent, investigate, mitigate, and control 
current, emerging, and new public health threats and to conduct 
research and development that lead to interventions for such threats.” 
 
So, new methods of disinfection should be developed in order to protect people, 
not only from current waterborne pathogens, but also to protect us from new 
emerging heath threats due to drinking water. 
Photodynamic inactivation (PDI) of pathogens is a unique approach to 
water treatment.  PDI, in general, consists of a chromophore that absorbs energy 
from light, and ultimately uses that energy to inactivate pathogens via singlet 
oxygen.  One method of PDI, called Photodynamic Therapy (PDT), is an 
approved treatment for several cancers 5-9.  While PDI and PDT both rely on the 
same photodynamic processes, in the present work, PDI is used to describe the 
application of those processes to disinfection where PDT refers to the cancer 
treatment. 
The use of photodynamic processes is not a new phenomenon by any 
means.  Much of the recent work using photosensitizers (PSs) has been geared 
toward developments in PDT, yet many of the findings are still relevant to PDI.  
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Furthermore, the use of synthetic porphyrins, our PS of choice, was originally 
developed for PDT of cancers.   
The oldest documented use of PSs was over 3000 years ago in India, 
where psoralens and light were used to treat vitiligo15.  In 12th century AD, 
Egyptians also used psoralens as a treatment for leucoderma8.  Modern methods 
of PDI/PDT began to emerge in the 1900’s.  In 1903 Herman Von Teppeiner 
used eosin and sunlight to treat skin tumors in mice.  In 1907 he also showed 
that oxygen was required for the photodynamic killing of tumor cells.  Similar 
observations were made with chlorophylls and erythrocyte hemolysis in 1907 and 
19198.  By 1911, experimentation on the photosensitization of mice with 
hematoporphyrin (Hp), a compound naturally found in the body, was well 
underway 6, 16.  In 1913, Hp was found to cause photosensitization in man when 
Friedrich Meyer–Bertz injected himself with 200 mg of Hp and observed no 
adverse effects until he was exposed to light 6, 8, 16.  
In 1924, it was found that natural porphyrins in tumors could give off 
fluorescence 6, 8, 16, while in 1942, Hp was found to accumulate in tumors.  This 
ability of the natural porphyrins to accumulate in tumors and give off fluorescence 
was first developed to detect and quantify tumor growth.  In 1960-61, Hp 
derivatives (HpD) were synthesized and used for tumor detection 17.  HpD would 
be used for tumor detection throughout the 1960’s.  
Throughout the 1970’s, Hp and HpDs were developed for PDT.  Tumors 
were first successfully treated in rats 18,19, which led to the first clinical trials of 
HpD by the end of the decade 20-22. 
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To date photosensitizers activated by light are being used as a treatment 
to stop uncontrolled cell growth.  PDT is an accepted treatment for macular 
degeneration as well as several types of cancer 5-9.  In PDT the photosensitizer is 
delivered to the target area and activated, often with lasers, to bring about a 
cytotoxic effect.  PSs and light have been shown to kill all classes of pathogens: 
bacteria, viruses, parasites and fungi 23-26.  Although PDI has been documented 
in various aqueous media, such as natural waters and blood plasma, its 
application to drinking water is relatively new.  
There are two types of photodynamic processes in PDT/ PDI.  In the type I 
process, the excited PS directly undergoes hydrogen or electron transfer with 
biological substrates that, when oxidized, impairs some cell function.  The type II 
process involves the excited PS transferring energy to dissolved oxygen to 
produce reactive oxygen species (ROS), most likely singlet oxygen, which then 
oxidizes biological substrates. See Figure 1.1. 
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Figure1.1 A general diagram of the photodynamic process 8. 
 
 
*Sn represents the various energy levels, and T1 represents the excited PS. This figure was 
obtained from Pushpan et al.8  
 
The efficiencies of both PDI and PDT are dependent on the following PS 
properties 9: 
I.  Lipophilicity and ionization 
II. Molar extinction coefficient 
III. Quantum yield of triplet state 
IV. Redox potential of the excited porphyrin 
V. Yield of singlet oxygen 
 
I. Lipophilicity and ionization- The lipophilicity and ionization affect the PS’s 
association and ultimate incorporation into the target pathogen or cell.  
Amphiphilic character can be helpful for PS mobility through cell walls and 
membranes, as well as through intercellular spaces.  The active agent in PDI is 
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either the excited PS or the reactive oxygen species.  Both are very short lived 
and must be in close proximity to the target to have a biocidal effect. 
 
II. Molar extinction coefficient- The molar extinction coefficient is a measure of 
the ability of the PS to absorb specific wavelengths of light.  The extent of PS 
activation is proportional to the light energy absorbed by the PS.   
 
III. Quantum yield of triplet state- The Quantum Yield of the triplet state is the 
amount of excited PS produced relative to the photons absorbed from light.  
There are two ranges of light that seem most promising in PDI.  The visible light 
range (400-650 nm) is the range of ambient light that can be detected by the 
human eye and electrically.  This range allows for inexpensive light sources in 
which the PDI could take place in a natural environment supported by sunlight.  
The second range of long wavelength light (650-900 nm), although much more 
expensive to produce, can allow for deeper penetration into tissues (PDT) as well 
as through turbid waters (PDI).  In terms of drinking water treatment, the 
disinfection processes generally take place after coagulation and flocculation, 
which removes most, if not all, of the turbidity. 
 
IV. Redox potential of the excited porphyrin- The redox potential of the excited 
PS is valid for the type I process in which the PS directly oxidizes biological 
substrates of the target pathogen or cells.  The redox potential is a measurement 
of how well the excited PS could oxidize those substrates. 
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V. Yield of singlet oxygen- The yield of singlet oxygen pertains to the type II 
reaction, in which the excited PS transfers its energy to molecular oxygen to 
produce the biocidal singlet oxygen that inactivates pathogens.  Singlet oxygen is 
believed to be the active ROS in PDI.   
 
Other important PS characteristics needed for the practical application of  
PDI include an economic synthesis, low native state toxicity, and rapid 
elimination from the body 8.  PSs used in water treatment will undoubtedly have 
to compete with the most inexpensive methods of disinfection, such as chlorine, 
which will require a reasonably simple and inexpensive synthesis.  If used in 
drinking water treatment, some amount of the PS will be ingested, which will 
require the PS to be both nontoxic in the absence of light and rapidly eliminated 
from the body to reduce the potential adverse health effects due to PDI. 
Since the development of Hp and HpDs for cancer treatment, several 
other PSs, naturally occurring and synthetic, have been selected to try to 
increase the efficiency of PDT based on the above-mentioned characteristics of a 
good PS6.  Each PS still has some drawbacks and there has not been one PS 
that is accepted as an agent for all PDT.  In both PDT and PDI, increasing the PS 
association with target cells and/or pathogens is key; close association with the 
target pathogen is important given the short-lived ROS ultimately responsible for 
inactivation.  Singlet oxygen, which is thought to be the biocidal species in most 
photodynamic processes, has a lifespan of 100-250 ns and an estimated 
diffusion distance of roughly 50 nm in aqueous media6, 31.  So, as a result, the 
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active agent will travel less distance than the diameter of the target malignant 
cells in PDT and the bacterial cells in PDI.  For effective killing of both tumor cells 
and pathogens, the PS’s association with the target is likely equally or more 
important than its overall production of singlet oxygen. 
Much of the latest developments in PDT have been geared toward the 
production of PSs that specifically target malignant cells so as to reduce the 
generalized killing of healthy cells.  In general, PSs bound to conjugates for 
receptors on target cells have been used to increase the efficiency of PDT.  This 
selectivity both increases the toxicity to malignant cells and reduces toxicity to 
healthy cells in PDT.  For example, chlorin-bound microspheres have been found 
to increase PDT of human bladder carcinoma cells 27.  Also anti-estrogen 
conjugated porphyrins have been shown to increase the efficiency of PDT in 
MCF-7 breast cancer cells 28.  Even PSs bound to internalizable ligands and 
proteins that are recognized by and actively transported into the cell nucleus 
have proven to improve PS association with and uptake by the cell 7.  Subtle 
changes to the PS can also result in large increases in efficiency.  Small 
increases in the aliphatic chain length bound to PSs were shown to increase 
lipophilicity of the compound and its uptake by cells 29.  
 The charge on the PS also plays a role in its interactions with the cell 
membrane 30.  Recent studies have shown that cationic PSs, irradiated with light, 
are more efficient than anionic PSs in the inactivation of non-enveloped viruses 
and gram-negative bacteria14, 32-40, two types of pathogens that are more 
resistant to currently used disinfectants than their gram-positive or non-
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enveloped counterparts.  It is believed that the positive charge on cationic PSs 
help them to better associate with the predominantly negatively charged surfaces 
on  non-enveloped viruses and gram-negative bacteria, thus bringing the PS in 
close proximity to the target pathogen.  Furthermore, since the above and other 
parasitic pathogens, such as Cryptosporidium parvum and Giardia lamblia,  that 
are most resistant to current methods of disinfection all have a net negative 
charge, cationic PSs are often the focus of PDI. 
 Using the latest developments in PDT as a model, it would seem that PSs 
could be developed to specifically inactivate pathogens in drinking water and 
other aqueous media.  Small amendments to a PS’s structure and properties 
could make the PS more efficient for the PDI of aqueous media.  
 Porphyrins are one group of chromophores proven to be effective in the 
inactivation of viral, bacterial, and fungal and parasitic pathogens6, 8, 24, 32, 38-41 
(See Appendix 1).  Porphyrins are naturally occurring in the body and are 
believed to be less toxic than other PSs with chemical structures that are 
completely xenobiotic. A cardinal characteristic of porphyrins is their ability to 
accommodate various substituents bound to the macrocycle.  Changing the 
substituents alters the reactivity of the porphyrin, and can allow for advanced 
disinfection control and specificity.   
Initial tests have shown the porphyrins to be active in the presence of light 
at concentrations that have no biocidal effect in the dark39, 41.  This makes the 
porphyrins very appealing as disinfectants because, if ingested, their toxicity is 
reduced in the absence of light.  This disinfectant with a non-toxic residual, in 
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theory, could be used for treating various aqueous media such as drinking water 
and blood products 10-14. 
Previously synthesized cationic porphyrins that have been proven to 
inactivate non-enveloped viruses and gram-negative bacteria in aqueous media 
have had fixed positive charges located on the periphery of the tetrapyrrole 
macrocycle 37-41.  To date one study has included a porphyrin with a more flexible 
cation position; while in this study the flexible cation gave the most efficient PDI, 
the effect of the cation position was not directly observed39.  In the present study, 
the positive charge is connected farther from the tetrapyrrole macrocycle through 
an aliphatic carbon chain to give the porphyrin added flexibility to associate with 
the negative regions on the surface of the target pathogens (See figure 1.2). 
 
Figure 1.2 An example of a fixed (right) and flexible (left) cationic meso 
substituted porphyrins.*   
                                                                                
 
 
 
 
 
 
 
 
*The newly synthetisized porphyrins (left) vary in the chain length linking the cationic pyridinium.  
Porphyrins described in previous literature (right) have a more rigid cation position in which the 
pyridinium is directly attached to the macrocycle. 
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A series of porphyrins were tested against model pathogens E. coli C3000 
and FAmp, Salmonella LT2, and bacteriophages MS2 and PRD-1.  MS2 and 
PRD-1 are examples of non-enveloped viruses, which have ssRNA and dsDNA 
respectively.  MS2 has also been previously documented as a model for the 
hepatitis A virus 42, 44.  The inactivation of non-infectious strains of E. coli is used 
to offer understanding of the porphyrins’ efficiency against bacteria commonly 
used as an indicator of fecal contamination45. Salmonella, which is the host for 
PRD-1, served as a second representative gram-negative bacteria.  
In order for this class of porphyrins to become useful in a public health 
setting, this group of porphyrins must be characterized for use in water treatment.  
Specific questions must be answered as to better understand the porphyrins’ 
stability in storage and in use, native state toxicity, and other factors that 
influence PDI efficiency.    
Porphyrin analogs to the above-described porphyrins that have the 
positive charge connected at the periphery of the porphyrins’ macrocycle were 
also synthesized in order to observe the effects of the positive charge location on 
various properties relevant to PDI.  The singlet oxygen production and the final 
localization of porphyrin associated with the target cells were also measured 
Specific Aims 
 This research was intended to develop the use of a novel series of 
photoactive cationic porphyrins as disinfectants for fluids such as water and 
blood products.  In order to move forward in implementing their possible 
applications as disinfectants, a greater understanding of these agents’ 
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mechanism of action, potential for toxicity, and stability in use is needed.  A 
series of experiments was conducted to better define the porphyrins’ applicability 
to the disinfection of water and other aqueous media and answer the following 
questions. 
(1) What is the optimum chain length for porphyrin inactivation of model 
pathogens?  The cationic porphyrins used in previous tests have carried fixed 
positive charges on the periphery of the tetrapyrrole macro cycle37-41.  Porphyrins 
with a more flexible cation linkage have been synthesized to adapt to various 
negative charge distributions on the surface of pathogens.  These porphyrins 
have cations attached to the porphyrin through an aliphatic carbon chain.  The 
inactivation of model pathogens by a range of meso substituted porphyrins with 
the cation positioned at various chain lengths was measured. 
(2) What is the stability of the porphyrins under various conditions that 
simulate likely real-life use? There is a need to better understand how long the 
porphyrin maintains its integrity when irradiated as well as in the absence of light. 
In this study, the photostability of four porphyrins that differ only in the mobility of 
the cation was examined.  The formation of degradation products was observed 
using 1H NMR, UV/Vis and mass spectrometry. 
(3) What is the potential toxicity of the porphyrins and their degradation 
products?  The toxicity of the parent porphyrins and the photoproducts to model 
mammalian cells was measured in order to understand the potential adverse 
effects of porphyrin use.  The control data from the inactivation experiments also 
offered insight to the toxicity of these porphyrins in the absence of light. 
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4) How does the attachment of the cation to the porphyrin periphery affect 
the binding to and subsequent inactivation of specific bacteria and 
viruses?  The efficiency of PDI of the above-mentioned porphyrins and their 
fixed cation analogs was observed to better understand the effect of the flexible 
cation position.  The amount of porphyrin bound to the target microbe was also 
measured and compared to each of the porphyrins’ inactivation of model 
pathogens. 
(5) Will long-wavelength light excite the porphyrins to a level effective in 
disinfection?  Porphyrins have a maximum absorbance at 411-430 nm, but are 
able to absorb longer wavelengths of light, up to 650 nm, to a lesser degree.  If 
this longer wavelength light is still able to excite the porphyrins above the 
threshold for a biocidal effect, these porphyrins could be used for a wider variety 
of settings that require deeper light penetration of media. 
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Chapter 2: Porphyrin Synthesis and Determination of Optimal Chain Length 
for Inactivation  
Background 
Photoactive disinfectants are of great interest as alternative measures 
against microbial contamination of aqueous media.  To date, photosensitizers 
(PSs) and light have been shown to kill all classes of pathogens; bacteria, 
viruses, parasites and fungi 1-4.  While Photodynamic inactivation (PDI) has been 
used in various aqueous media, its application to drinking water is relatively new.  
   Porphyrins prove to be an interesting PS for a number of reasons.  
Perhaps the greatest reason that porphyrins demand closer investigation is the 
variety of substituents that can be placed on the porphine skeleton.  The most 
familiar porphyrin, found in hemoglobin and myoglobin, is porphyrin IX, which has 
many substituents.  Changing the substituents on the porphyrin can increase the 
physico-chemical interaction with specific molecules; thus, porphyrins can be 
tuned to promote PDI. 
In general, the pathogens of concern in modern drinking water treatment 
all have surfaces with a net negative charge 5.  Cationic substituents are believed 
to increase both the porphyrin association with the negatively charged surfaces 
and the photolytic activity against the pathogens of concern.  Most of the 
previously synthesized cationic porphyrins that have been proven to inactivate 
non-enveloped viruses and gram negative bacteria in aqueous media have had 
fixed positive charges on the periphery of the tetrapyrrole macrocycle6-14.  By 
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connecting the positive charge farther from the tetrapyrrole macrocycle through 
an aliphatic carbon chain, the porphyrin flexibility to associate with the negative 
regions on the surface of the target pathogens is increased (See figure 2.1).  
 
Figure 2.1 The structure of a generic meso-substituted porphyrin.*   
                                                                                
 
 
 
 
n=1 meso- tetrakis(1-methy-4-pyridyl) porhyrine tetra- p- tosylate (TMPyP) 
n=3 meso- tetrakis (3-[N-pyridiniumyl] propyl) porphyrin                (C3PyP) 
n=4 meso- tetrakis (4-[N-pyridiniumyl] butyl) porphyrin                  (C4PyP)  
n=5 meso- tetrakis (5-[N- pyridiniumyl] pentyl) porphyrin               (C5PyP) 
n=7 meso- tetrakis (7-[N- pyridiniumyl] heptyl) porphyrin               (C7PyP) 
n=11 meso- tetrakis (11-[N- pyridiniumyl] undecyl) porphyrin        (C11PyP) 
 
*Our synthetic porphyrins vary in the length of the aliphatic bridge which isolates the cationic 
center from the tetrapyrrolic macrocycle. The porphyrins used in this study (and their 
abbreviations) based on the figure are as follows. The TMPyP porphyrin (from previous literature) 
has a tosylate counterion, whereas the others have bromine. 
 
 
While there has been documentation of the potential of flexible cationic 
porphyrins14, few studies have observed the effect of the length of the aliphatic 
bridge between the porphyrin macrocycle and the cationic pyridinium.  In pursuit 
of the first specific aim of this research, the above porphyrins were synthesized 
N
NH N
HN
R
R
R
R
R= (CH2)n N
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and tested against E. coli in order to determine an optimal chain length for 
porphyrin PDI.      
Materials  
 
Porphyrin Synthesis  
Solvents methylene chloride, ether, and dimethyl formamide (DMF), and 
the reagent zinc acetate dihydrate were obtained from Fisher Scientific.  Other 
solvents chloroform, hexane, ethyl acetate, and methanol were obtained from 
Mallinckrodt Chemicals.  Reagents ethyl 4-bromobutyrate, ethyl 6-
bromohexanoate, pyrrole (98%), pyridine (99%) HPLC grade, carbon 
tetrachloride (99%) HPLC grade, lithium aluminum hydride (95%), trifluoroacetic 
acid (99%), and pyridinium chlorochromate (PCC) (98%) were obtained from 
Sigma Aldrich.  The p-chloranil (PCA) was obtained from Kodak.  Montmorillonite 
clay K10, florasil 100- 200 mesh, filter agent celite 521, alumina gel, standard 
grade, 50 mesh, 58 Ǻ and silica gel, merck grade 9385, 230-400 mesh, 60 Ǻ 
were also obtained from Sigma Aldrich.  All solvents were evaporated using a 
Büchi Rotovapor R-114.  ¹H NMR spectra were recorded on a Varian INOVA 500 
spectrometer at 500 MHz and 25°C, using chloroform- d as the solvent.  Mass 
spectra were obtained on a Finnigan LCQDECA quadrupole ion trap mass 
spectrometer with electrospray source operated in the positive mode. TMPyP 
was purchased directly from Aldrich Chemical Co., Milwaukee, WI.   
Inactivation Experiments  
USB Agar was obtained from Amersham International, Cleveland, OH.  
Bacto tryptic soy broth (TSB), glycerine, and tryptic soy agar (TSA) were 
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obtained from Becton, Dickinson and Co.  E. coli strain C3000 was obtained from 
ATCC 15597.  A Phillips 40 W Hg fluorescent light (F40T12/DX), positioned 
11.25 inches above the wells (measured by ruler), was used to irradiate samples 
at 0.48 mW/cm2 measured by light meter (Mannix DLM2000).   
Methods 
Porphyrin Synthesis  
All porphyrins except TMPyP were synthesized in our laboratory according 
to Figure 2.2 which was adapted from literature methods15-20. The product 
identity and purity was confirmed by 1H NMR between each step in the synthesis. 
The synthesis of the tetrakis(N-propyl) derivative, C3PyP, is described in detail 
below . Additional 1H NMR and MS spectra can be seen in Appendix 2. 
Figure 2.2 General scheme for porphyrin synthesis, applied to C3PyP* 
 
*All porphyrins were synthesized according to figure 2.2 using the appropriate ester except 
TMPyP, which is commercially available. 
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1) Lithium Aluminum Hydride (LiAlH4) Reduction16 
In a 500 mL flask, 15 g ethyl 4-bromobutyrate was combined with lithium 
aluminum hydride in a 1:1 molar ratio.  The hydride was added to 100 mL of 
ether and refluxed at 40°C while the ethyl 4-bromob utyrate was diluted with 60 
mL ether and added dropwise.  The stirred solution was refluxed for 1 hour.  The 
mixture was then cooled in ice and 10 mL saturated aqueous sodium chloride 
was added dropwise.  Here the solution’s gray color may yield some white 
precipitate of LiOH.  The LiOH was then removed by filtration under vacuum 
through a sintered glass funnel, and the clear solution was evaporated to yield a 
colorless alcohol stored at -20°C.  The alcohol was then a nalyzed using 1H NMR 
before going to the second step of the process. 
2) PCC Oxidation19 
The second step of this synthesis was a PCC oxidation using 3-5 g of the 
above alcohol in a 1:1.25 ratio with the PCC.  Here the PCC was combined with 
100 mL of freshly distilled methylene chloride and stirred to uniform suspension.  
The alcohol from step one, dissolved in 60 mL of methylene chloride, was added 
and stirring was continued for 1 hr at room temperature.  Stirring may slow down 
or stop toward the end as a result of the formation of thick chromium salts.  The 
mixture was diluted with 100 mL of ether, sonicated, and separated on a 1” x 6” 
silica column eluted with methylene chloride.  The green portion of the eluate 
was collected and further purified on a 1” x 5” silica column eluted with ether.  On 
the second column the colorless aldehyde was collected as the target compound, 
confirmed using 1H NMR, evaporated, and stored at -20°C.   
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3) Condensation 
The third step of this synthesis was a condensation of the above aldehyde 
and pyrrole in a 1:1 molar ratio17,18.  3 g of the aldehyde and the corresponding 
portion of dry pyrrole were mixed with 100 mL of carbon tetrachloride (CCl4) 
under argon for 15 min.  1 mL of trifluoroacetic acid was injected into the mixture 
as a catalyst.  The argon was cut off and the mixture was allowed to stir for 24 
hrs at room temperature.  The CCl4 was removed by evaporation, and the dry 
residue was dissolved in 50 mL of methylene chloride and separated on a 1” x 6” 
alumina column eluted with chloroform.  The eluate was then evaporated to 150 
mL and refluxed with 300 mg p-chloranil for 40 min.  The solution was separated 
on a 1” x 6” alumina column eluted with chloroform, evaporated to 10 mL, and 
further purified on a 1” x 7” silica column eluted with 1:1 hexane to chloroform.  
Finally, the solution containing the porphyrin freebase was evaporated and 
stored at -20°C. 
 A second method for condensation was also used in an effort to achieve a 
better yield15,20.  In this method, 10 g of montmorillonite clay was activated at 
120°C and below 0.5 Torr for 2 hrs in a 2 L round bo ttom flask.  Next, the system 
was filled with argon and shielded from light.  950 mL of freshly distilled 
methylene chloride and 10 mmol of the aldehyde dissolved in 50 mL of 
methylene chloride were added to the flask.  The mixture was stirred to uniform 
suspension, 10 mmol of pyrrole was introduced dropwise, and the mixture was 
allowed to stir for 24 hrs.  7.5 mmol of solid p- chloranil was added to the 
solution, and it was refluxed at 45°C for 1 hr.  The solid was filtered though celite 
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under vacuum and washed with ethyl acetate.  The filtrate was reduced and 
absorbed onto florisil.  The absorbate was then purified by column 
chromatography though two separate 1” x 6” silica columns using methylene 
chloride.  The solution was then evaporated and stored at -20°C.  The solid 
product was analyzed with 1H NMR and UV visible spectroscopy before the next 
step.  The presence of the porphyrin can also be determined by the property of 
the porphyrin to yield a red fluorescence under long wave UV light. 
4) Quaternization 
The fourth and final step of this synthesis was a quaternization using the 
porphyrin produced from the above condensation procedure and pyridine.  50 mg 
of the porphyrin freebase was combined with 12 mL dry pyridine, and refluxed 
under argon gas for three hours.  The solid pyridinium porphyrin was removed 
and washed with ether.  Excess ether was removed and the solid was dried 
using a rotovapor, oil pump, and lyophilizer.  The final product was confirmed via 
1H NMR. 
 A total of five different quaternized porphyrins were synthesized via the 
above methods.  These porphyrins have positive charges connected through 
three, four, five, seven, and eleven carbon chains.  The above describes the 
synthesis of the C3PyP porphyrin with four propyl substituent chains at the meso 
positions of the ring.  To form the analogous porphyrins with the 4, 5, 7, and 11 
carbon substituent chains, ethyl 5-bromovalerate, ethyl 6-bromohexanoate, 8-
bromo-1-octanol, and 12-bromo-1-dodecanol were used respectively instead of 
ethyl 4-bromobutyrate as the starting material.   
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Inactivation Tests 
All steps of the inactivation tests except for microbe incubation were 
performed in a biological safety cabinet.  All inactivation experiments were done 
in triplicate.  Only the average, not the individual values of the replicates, are 
shown in the results section.  The Thomas Equation was used to calculate the 
concentration of both the bacteria and viruses. 
The above-mentioned porphyrins were used in experiments to measure 
their efficiency in killing E. coli C3000 according to the following protocol.  The E. 
coli stocks were made by first inoculating into 30 mL sterile TSB made to the 
manufacturer’s specifications and then incubating at 37˚C for 18 hrs in a forced 
air incubator with a shaker.  100 µL of the E. coli culture was then re-inoculated 
in 30 mL of sterile tryptic soy broth and incubated for 4 hrs.  This four-hour E. coli 
culture was diluted with glycerine in 3:1 ratio, E. coli to glycerin, and divided into 
1mL aliquots and kept at -80˚ C until further use. 
For each experiment the above was repeated using the frozen stocks for 
inoculation.  The four-hour culture of E. coli was diluted with sterile deionized 
water (DIW) in a 2:1 ratio of water to E. coli suspension to make the bacterial test 
mixture.  1 mL of the E. coli mixture was added to a sterile well culture plate 
along with 10 µL of a 0.1 mM porphyrin solution in sterile DIW.  This yielded a 
final porphyrin concentration of 1 µM.  Controls were made with the addition of 10 
µL of DIW to 1 mL of the E. coli suspension instead of the porphyrin. The entire 
plate was then placed under fluorescent light for as long as 30 min.  Additional 
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controls made with plates identical to that above, were shielded from all light for 
30 min. 
Duplicate serial dilutions were made from each well, experimental and 
control, at 10, 20, and 30-minute intervals. Once the final concentrations were 
achieved, 100 µL of the each dilution from each well was added to 2.5 mL of 
sterile molten top agar (0.7% agar) kept at 45˚C.  The samples were then 
vortexed, poured onto a Petri dish containing 15 mL of TSA, made to the 
manufacturer's specifications, and allowed to cool and solidify.  The plates were 
then incubated for 20 hrs in a shelf incubator set at 37˚C.  After this incubation, 
the E. coli colonies on each of the plates were counted.  In most cases there 
were three consecutive countable 10-fold dilutions.  All countable dilutions were 
used to obtain a value of colony forming units (CFU)/mL.   
The porphyrins were also tested against the coliphage MS2. The MS2 
stock was made by adding 10 µL of  concentrated MS2 ( ~7 x 1011/mL) and 300 
µL of the undiluted four-hour E. coli culture to 5 mL top agar made of TSB with 
0.3% agar.  The top agar was gently mixed and poured onto a large Petri plate 
containing 25 mL of TSA.  The plates were then incubated for 20 hours at 37˚C.  
5mL of phosphate buffered saline (PBS; pH 7) was then added to each plate, 
and the loose top layer was scraped off and centrifuged at 4500 rpm for 20 
minutes at 4˚C.  The supernatant was then passed through a 0.45 µm filter, and 
1 mL aliquots were made and stored at -80˚C until further use. 
  For MS2 inactivation tests, 10 µL of a 0.1 mM porphyrin solution in sterile 
DIW was added to 1 mL of the MS2 suspension (~1-4 x109 PFU/mL).  After one 
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minute of light irradiation the test mixture was serially diluted.  100 µL of the 
diluted test mixture was added to 200 µL of the E. coli culture, described above, 
in 2.5 mL of top agar made of TSB with 0.7% agar kept in a water bath kept at 
45˚C.  This mixture was gently swirled and  poured onto a Petri dish containing 
15 mL of tryptic soy agar (TSA) made to the manufacturer's specifications and 
allowed to cool and solidify. These plates were then inverted and incubated for 
20 hours at 37˚C.  All countable plates were used to obtain a value of plaque 
forming units (PFU) per mL 
Results 
Synthesis 
The results described below are for the synthesis of the C3PyP porphyrin.  
All of the porphyrins have similar 1H NMR spectra, however with each 
increasingly long substituent chain, an additional peak will occur in or to the right 
of the region of the C2 substituent carbon described below.  In general, the 
porphyrins become increasingly difficult to purify with the increase in carbon 
chain length. The 1H NMR (for the synthesis of C3PyP) of the starting compound, 
each intermediate compound and the final product can be seen in Figures 2.3-
2.7. 1H NMR and mass spectra of the other porphyrins can be seen in Appendix 
2.  The percent yield for each step can be seen in Table 2.1. 
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 Table 2.1 The percent yield for each reaction in the porphyrin synthesis. 
 
LiAlH4 Reduction 
 The carbonyl group of the ethyl-4-bromobutyrate was reduced with LiAlH4  
to give 4-bromobutanol.  This process is done with 60-70% yield.  This reduction 
was performed using different concentrations of LiAlH4 and ethyl 4-
bromobutyrate and the more dilute solutions tended to give a better yield.  1H 
NMR spectra were used to confirm the new product and its purity.  The most 
noticeable peaks in the 1H NMR spectrum consisted of two triplets at centered at 
3.4 and 3.7 ppm and two quintets centered at 1.7 and 1.9 ppm.  The triplets at 
3.4 and 3.7 ppm are due to the CH2 groups next to the Br (C4) and the OH (C1) 
group, respectively.  The two quintets correspond to the two interior CH2 groups 
on the alcohol (C2 & C3).  Purity is noted from 1H NMR before measuring 
amounts for the next step (See Figures 2.3 and 2.4).  For example, if the product 
is 50% pure, then twice as much was used for the next step.  
 
 
 
 
 
Reaction Starting Material Product % Yield 
LiAlH4 Reduction 10.5g 7.4g 70.5% 
PCC Oxidation 5.4g 3.1g 62.2% 
Condensation (trifluoroacetic acid) 3.7g 22mg 0.6% 
Condensation (clay) 2.85g 620mg 12% 
Quaternization (pyridine only) 10mg 10mg 100% 
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Figure 2.3 1H NMR of ethyl- 4-bromo-butyrate from the spectral data base  
 
 
Figure 2.4 1H NMR of 4-bromo-1-butanol after the LiAlH4 Reduction (CDCl3) 
 
 
PCC Oxidation 
 Here the alcohol was converted into the aldehyde (BrCH2CH 2CH2CHO) 
and the chromium ion was reduced from Cr6+ to Cr3+.  This oxidation has a 60-
70% yield.  The 1H NMR (Figure 2.5) revealed target peaks as a triplet centered 
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at 9.8 ppm for the proton attached to the carbonyl group (C1), a triplet centered 
at 3.4 ppm for the hydrogens at C4, a quartet centered at 2.7 ppm for the protons 
on C2, and a quintet centered at 2.2 ppm for the protons on C3.  The triplet at 9.8 
ppm may appear as a single peak because of its very low coupling constant.   
 
Figure 2.5 1H NMR of 4-bromo-1-butanal after the PCC oxidation (CDCl3) 
 
 
Condensation 
 In this step the aldehyde was connected to the pyrrole at the meso 
position to form a porphyrin ring consisting of four pyrroles and four propyl 
chains.  This procedure was done in very low yield (0.6%).  The C1 that was 
once an aldehyde group now forms the methine bridge of the porphyrin ring.  The 
1H NMR (Figure 2.6) yielded four peaks as confirmation of the porphyrin.  There 
is one peak centered at 9.6 ppm corresponding to the presence of pyrrole, two 
triplets centered at 5.1 and 3.8 ppm corresponding to the substituent chain 
protons on C1 and C3 respectively, and one quintet centered at 3.1 ppm for the 
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protons on C2 of the substituent chain.  The presence of porphyrin was also 
noted by its dark purple color.  In solution the porphyrin gives off red 
fluorescence under long-wave UV light and it turns green in the presence of 
hydrochloric acid.  The UV/Vis spectrum was also taken in chloroform to confirm 
the compound. 
Figure 2.6 1H NMR after the Condensation step (CDCl3) 
 
 
The clay condensation improved the percent yield by more than 20 fold 
with a 12% yield (Table 2.1).  The clay absorbed and removed many of the 
oxidants and polymeric by-products.  The pores in the clay acted as a template 
for the formation of the bulky porphyrin molecule20. 
Quaternization of Pyridine 
 Here the bromine atom located at the end of each of the four substituent 
chains was replaced with pyridine where the nitrogen holds a positive charge.  
This reaction produces a water-soluble porphyrin with 1H NMR peaks as follows:  
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broad doublet centered at 9.2 ppm as pyrrole protons, a doublet at 9.1 ppm and 
triplets at 8.4 and 8.0 ppm that correspond to protons at the ortho, para, and 
meta positions on the pyridine respectively, a triplet at 5.2 ppm for protons on C1 
and C3 of aliphatic substituent chain, and a quintet at 3.3 ppm for protons on C2 
of the aliphatic chain.  UV/Vis spectra were recorded in water and methanol.  
Figure 2.7 shows the 1H NMR of the final pyridinium porphyrin salt.   
 
Figure 2.7 1H NMR of the final product C3PyP (CD3OD) 
 
 
Inactivation Experiments  
The most effective porphyrins against E. coli were found to be those 
where the cation is at the end of a propyl, butyl, or pentyl, substituent chain 
(Table 2.2).  Several inactivation times were examined for both E. coli and MS2.  
The data shown is for 30 minutes irradiation for E. coli and 1 minute for MS2.  
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These times were chosen based on the observance of equally extensive 
inactivation of E. coli and MS2 (~6 logs) as well as time constraints of the 
procedure.  Since the porphyrins are more active in the light than in the dark, the 
MS2 dark samples are allowed 30 minutes rather than the 1 minute for irradiated 
samples to measure significant inactivation in the absence of light.  
 
Table 2.2 Porphyrin inactivation of undiluted E. coli* 
Porphyrin 
 
(1µM) 
Log Reduction (Standard Deviation) 
Light Dark 
C3PyP 4.36(0.38) 0.38 (0.09) 
C4PyP 4.30 (0.22) 0.09 (1.17) 
C5PyP 4.94 (0.05) 0.15 (0.06) 
C7PyP 3.45 (0.26) 
 
0.48 (0.13) 
C11PyP 0.30 (0.05) 0.08 (0.003) 
  
*Data were obtained from 30 min irradiation with a 40 W Hg fluorescent light (0.48 mW/cm2) 
11.25” (measured by ruler) from wells with porphyrin and E coli C3000. Experiments were done in 
triplicate with duplicate samples. There was no reduction in the concentration of E. coli samples 
exposed to light in the absence of porphyrin.  
 
The E. coli inactivation was performed on two different E. coli mixtures. The 
original mixture (results shown in Table 2.3) was undiluted whereas in later 
experiments the mixture was diluted with 2:1 DIW to E. coli stock.  From the 
original trials of the undiluted mixture, the C3PyP, C4PyP, and C5PyP exhibited 
efficient inactivation of E. coli while the C7PyP and C11PyP offered less 
inactivation.  Based on their easier purification and greater inactivation, these 
three porphyrins and the commercially available meso-tetrakis(1-methy-4-pyridyl) 
21H, 23H- porhyrine tetra-p- tosylate (TMPyP) were used in the E. coli and MS2 
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experiments that follow (See Figure 2.8).  When the diluted E. coli mixture was 
used an increase in the inactivation was observed for the C3PyP and C4PyP, but 
the C5PYP decreased.  See Table 2.3. 
 
 Figure 2.8 The name and structure of porphyrins used in inactivation 
experiments with E. coli and MS2 
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porphyrin tetrabromide (C3PyP) 
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                                     meso- tetrakis (5-[N- pyridiniumyl] pentyl) porphyrin              
tetrabromide (C5PyP) 
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Table 2.3 1µM porphyrin reduction of diluted E. coli *  
 
Porphyrin 
 
Light log reduction 
( Standard Deviation) 
C3PyP 5.69 (1.27) 
C4PyP 5.48 (0.37) 
C5PyP 3.86 (0.68) 
 
*The averages of three trials are shown.  There was no observed dark inactivation in up to 30 
min. E. coli solutions diluted 2:1, DIW: E. Coli was irradiated (40 W Hg fluorescent light,0.48 
mW/cm2) with 1 µM porphyrin for 30 min.   
 
The porphyrins had a much more rapid inactivation of MS2 than the E. coli.  
With the most efficient of the porphyrins, nearly 6 logs reduction of the E. coli 
was achieved in 30 minutes (Table 2.3) where it took just one minute with the 
MS2.  Without the irradiation, each of the porphyrins had less than one log 
reduction of both E. coli and MS2.   The MS2 reductions are shown in Table 2.4. 
  
Table 2.4 MS2 reductions with and without light* 
Porphyrin 
(1 µM) 
Log reduction (Standard Deviation) 
Light (1min) Dark (30 min) 
C3PyP 6.55 (0.71) 0.42 (0.17) 
C4PyP 6.02 (0.19) 0.23 (0.08) 
C5PyP 4.08 (1.14) 0.22 (0.14) 
*MS2 was irradiated with a 40 W Hg fluorescent light,0.48 mW/cm2. Data shown is the 
average of three trials. 
 
Additional experiments were done using the commercially available porphyrin 
TMPyP against the bacteriophage MS2.  This was done to compare the synthetic 
porphyrins inactivation to a similar compound with constrained positive charges. 
This porphyrin was measured at three concentrations:  0.1, 1.0, and 10 µM.  For 
each concentration, MS2 was measured at 1minute of light contact time, as well 
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as at 1 and 30 minutes of contact time in the absence of light.  Table 2.6 shows 
the results for the TMPyP experiments. 
 
Table 2.5 MS2 reductions using the commercially available TMPyP 
Concentration 
of TMPyP 
( µM) 
Log reduction ( Standard Deviation) 
Light 
(1min) 
Dark 
(30min) 
0.1 6.29 (0.02) 1.45 (0.10) 
1.0  < 9.17* 6.14 (0.27) 
10  < 9.17* 7.49 (0.95) 
*This data is below the limit of detection.  *MS2 was irradiated with a 40 W Hg fluorescent 
light,0.48 mW/cm2. Data shown is the average of three trials. 
 
Discussion 
A total of five porphyrins were synthesized and tested against E. coli, and 
the three most efficient porphyrins, C3PyP, C4PyP, and C5PyP, were more 
extensively tested against bacteriophage MS2.  Each of the porphyrins 
synthesized has four identical substituents at the meso position of the porphine 
ring.  This four-fold symmetry allows for a more straightforward procedure than 
would a synthesis of porphyrins with varying substituents.  All data collected 
showed that the synthesis was successful in producing five distinct porphyrins.  
In each step of the synthesis, reactions seemed to have greater yield as the 
reaction mixtures were more dilute.  In the condensation procedure, the use of 
the montmorillonite clay as a catalyst was much more effective than the method 
involving trifluoroacetic acid. 
For the inactivation experiments, large concentrations of both the bacteria 
and bacteriophage were needed in order to extensively measure inactivation by 
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the porphyrins.  The extent of inactivation and the ability to measure inactivation 
as a function of time was dependent on the rate of inactivation of each microbe, 
the concentration of microbes in solution, and the concentration of porphyrin 
used.  A measurement of inactivation as a function of time was not feasible for 
MS2, which showed greater than six-logs reduction (99.9999%) with just one 
minute of light exposure.  At five minutes the MS2 was reduced to below the limit 
of detection.    Although the target concentration of porphyrin was 1 µM (~1 
mg/L), which is comparable to drinking water limits on chlorine, inactivation was 
observed at 0.1 and 10 µM to ensure data within the limits of detection.  The1 µM 
porphyrin concentration is also appealing because at this concentration there 
was a high level of inactivation of E. coli with light with no significant dark toxicity.    
 The bacteria and all host cells used must be in the log phase of growth.  If 
non-viable bacteria compete for contact with the porphyrin, then the porphyrin will 
appear to be less efficient against the viable bacteria.  While contaminated 
waters in the environment would not contain bacteria in log phase growth, higher 
concentrations of bacteria are needed for a proof of concept for porphyrin use in 
PDI.  
 The amount of turbidity in solution also had an effect on the porphyrin’s 
efficiency as a disinfectant.  The E. coli solution used to obtain the primary data 
in table 2.2 was undiluted, while that for the data in table 2.3 was diluted with 
DIW. This dilution reduced the amount of suspended solids that can block light 
and compete for porphyrin contact, which lead to an increase in the overall 
inactivation of E. coli.   
39 
 
Turbidity, a measurement of cloudiness, was measured for both solutions 
of microbes.  This will give some information as to the stages of water treatment 
at which the porphyrin will be most effective and allow for comparison of the 
porphyrin data to that of other disinfectants used in water treatment processes.  
The most common disinfectants for drinking water are generally used as the last 
step in water treatment.  This occurs after most of the turbidity is removed from 
the water.  It is assumed that the lower the turbidity, the higher the porphyrin’s 
efficiency of inactivating the test microbes.   
When comparing the newly synthesized porphyrins to literature on free 
chlorine21, the most widely used disinfectant for water treatment1, the flexible 
cation porphyrins are potentially more powerful disinfectants.  Tables 2.6 and 2.7 
show the comparisons of the porphyrins’ and free chlorine inactivation of E. coli 
and MS2 respectively.  
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Table 2.6 Comparisons of C3PyP and free chlorine inactivation of E. coli 
System Characteristics Free Chlorine 21 C3PyP 
(present study) 
Microbe E. coli E. coli 
Disinfectant Concentration 100 mg/L 1 mg/L 
Temperature ˚C 25˚C 25˚C 
Nephelometric Turbidity 
Units (NTU) 
200 NTU 132 NTU 
Log Reduction (approx) 5 5 
Contact Time min 2 30 
CT constant mg·min/L 200 30 
 
Table 2.7 Comparisons of C3PyP and free chlorine inactivation of MS2. 
System Characteristics Free Chlorine 21 C3PyP  
(present study) 
Microbe MS2 MS2 
Disinfectant Concentration 100 mg/L 1 mg/L 
Temperature ˚C 25˚C 25˚C 
Nephelometric Turbidity 
Units (NTU) 
2 NTU 0.23 NTU 
Log Reduction (approx) 4 6 
Contact Time min 2 1 
CT constant mg·min/L 200 1 
 
Although the two studies were not done under the same conditions, the 
tests are similar enough to compare CT constant , which is the product of the 
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concentration (mg/L) of the disinfectant and the time needed (min) for a specific 
level of inactivation.   This value expresses a specific level of inactivation as a 
function of disinfectant concentration multiplied by contact time.  Tables 2.6 and 
2.7 show that the most efficient porphyrin offered more inactivation of the test 
microbes with a much smaller CT constant.  These preliminary studies have 
shown that these porphyrin compounds could be a more effective disinfectant 
than free chlorine, especially in turbid waters.   
With the comparison of TMPyP to our synthetic porphyrins in the 
inactivation of MS2, one can see that the TMPyP is much more lethal to MS2 
than the synthetic porphyrins.  This is true both in the presence and absence of 
light.  The increase in the MS2 inactivation in the absence of light is due to an 
increase in natural toxicity of the porphyrin (toxicity in the absence of light).  This 
shows that the TMPyP is not as inert in the absence of light as the other 
porphyrins tested, and could potentially have more adverse effects if ingested. 
This could very well be due to the different counter ions in the commercially 
available TMPyP and our synthetic porphyrins.  The synthetic porphyrins have a 
simple bromine counterion where as the TMPyP has a more complex, and 
potentially more toxic, tosylate counter ion.  In order to directly measure the 
effect of cation position, a series of fixed-cation porphyrins with identical 
counterions were synthesized.  These porphyrin analogs have the same 
molecular formula as our newly synthesized porphyrins, with the location of the 
cation being the only difference in structure.  This direct comparison was needed 
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to help to better understand the porphyrins’ mechanism of inactivation and the 
role of this series of porphyrins as potential disinfectants of the future.  
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Chapter 3: Porphyrin Photodegradation and Toxicity 
Background 
Photodynamic inactivation (PDI) of pathogens is an effective method of 
disinfection that has not been applied to water treatment. In PDI, a chromophore 
absorbs energy from light and ultimately transfers the energy to dioxygen to 
generate the singlet oxygen that inactivates pathogens.  Additionally, PDI is an 
appealing method of disinfection because its mechanism of action is not likely to 
lead to resistance, and if the photosensitizer (PS) is ingested, its toxicity is 
reduced in the absence of light.  The principles of PDI are evident in 
photodynamic therapy (PDT), an approved treatment for several cancers 1-5, and 
they have more recently been applied to the disinfection of blood products6-10.   
Cationic porphyrins are one class of chromophores that have proven to be 
effective in the inactivation of viral, bacterial, fungal and parasitic pathogens 2, 4, 
11, 16-18, 20, 23
.   In addition to being highly efficient PSs, the physicochemical 
properties of porphyrins may readily be tuned by altering the peripheral 
substituents.  Recent studies have shown that cationic porphyrins irradiated with 
light are particularly efficient in the inactivation of non-enveloped viruses as well 
as gram-negative bacteria in aqueous media 10-19.  It is believed that the cationic 
character affords better association with the predominantly negatively charged 
surfaces of non-enveloped viruses and gram-negative bacteria.  Furthermore, 
most pathogens of concern in modern drinking water treatment, have an overall 
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negatively charged surface 24.  To date, several studies have shown some 
connection between the cationic character of the PS and the association of that 
PS to gram-negative bacteria 11, 18, 20, 21.  
  The cationic porphyrins used in previous tests have rigidly attached 
positive charges on the periphery of the tetrapyrrole macrocycle.  In the present 
study, it is hypothesized that attaching cationic groups via more flexible, aliphatic 
links will allow for increased cation mobility and better adaptation to the shape 
and negative charge distribution on the surface of target microorganisms.  To 
evaluate this hypothesis we have synthesized porphyrin analogs to C3PyP and 
C4PyP, the most efficient porphyrins from the PDI experiments summarized in 
Chapter 2.  These porphyrin analogs have the same molecular formula and differ 
only in the cation position and flexibility.  The comparison of these porphyrins will 
allow for a direct observation of the effect of the cation position on various 
properties that effect PDI.  
To address the second and third specific aims of this research, the 
porphyrins’ stability and toxicity in the presence and absence of light was 
examined.  A better understanding of porphyrin stability with and without 
activation is critical for the practical application of these porphyrins and PDI in 
general.  A photostability test based on previous literature17 was used to monitor 
the degradation of each of the porphyrins.  In this study, the photostability of four 
porphyrins that differ only in the mobility of the cation was investigated. The 
formation of photoproducts was monitored, and an attempt was made to define 
the degradation products of these porphyrins using 1H NMR, UV/Vis and mass 
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spectrometry.  The toxicity of the parent porphyrins and the photoproducts to 
model mammalian cells was measured in order to understand the potential of 
adverse effects of these porphyrins.  The porphyrins incorporated into this study 
can be seen in Figure 3.1. 
Figure 3.1 The four porphyrins used in this study and their abbreviations 
 
                              Meso-tetrakis (3-[N-pyridiniumyl] propyl) porphyrin                 
tetrabromide (C3PyP) 
  
                  Meso-tetrakis (4-[N-pyridiniumyl] propyl) porphyrin  
                                                                tetrabromide (C4PyP) 
 
                          Meso-tetrakis (3-[N-propyl] pyridiuniumyl) porphyrin  
                           tetrabromide (TProPyP) 
 
            
                               Meso-tetrakis (4-[N-butyl] pyridiniumyl) porphyrin  
                                                                    tetrabromide (TBuPyP) 
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Materials and Methods 
Porphyrin synthesis  
The C3PyP and C4PyP porphyrins were synthesized in our laboratory as 
described in Chapter 2.  TBuPyP and TProPyP were synthesized from tetra 
meso pyridinium porphyrins (Frontier Scientific, Logan UT), which were refluxed 
with either 1-bromopropane or 1-bromobutane respectively to obtain the 
TProPyP and TBuPyP.  All porphyrins were purified by serial extractions from 
aqueous solution with chloroform, methanol, ether and water followed by 
lyophilization for 48 hours.  All other materials were obtained through Fisher 
Scientific. 
Porphyrin Photodegradation and Photoproduct Formation 
A stirred solution of 5 mL of 1 mM porphyrin in DIW in a 20 mL glass vial 
was irradiated with 300 W halogen projector (4.72 mW/cm2) for 24 hours.  
Aliquots (200 µL) were taken at time zero and once every hour for 6 hours and at 
24 hours.  To compensate for evaporation, the reaction vial was weighed at t=0, 
and before and after the removal of each aliquot (Sample calculations can be 
seen in the Appendix 3).  Each aliquot was frozen, dried by lyophilizer and 
analyzed by 1H NMR and MS.  At each sample time 10 µL of the test solution 
was diluted with 3% sodium dodecyl sulfate (SDS) in DIW to 10 µM, vortexed, 
and analyzed by UV/VIs.  Separately, the oxidation was observed under anoxic 
conditions by initially bubbling argon through the test solution for 30 minutes and 
maintaining positive argon pressure during the irradiation.  
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Porphyrin degradation was measured as the decrease in the Soret band 
at 416 nm (C3PyP and C4PyP) or 432 nm (TProPyP and TBuPyP).  The UV/Vis 
(Varian Cary 300) was scanned from 190-900 nm at 350 nm/min.  After 24 hours 
of irradiation, regardless if the Soret band had an appreciable decrease, the 
porphyrin and soluble photoproducts were transferred to sterile vials and stored 
at 4˚C until they were later used in the toxicity study.   
Toxicity to Mammalian Chinese Hamster Ovary (CHO) cells  
CHO cells were obtained from the American Type Culture Collection 
(ATCC) and maintained according to their specifications.  All porphyrin 
photoproducts in the following toxicity assay were irradiated for 24 hrs.  Various 
concentrations of the parent and degraded porphyrin were added to 4 mL of 
CHO cells (~220 cells/well) in PBS buffer (pH 7) in a six-well plate.  The plates 
were shielded from light and incubated at 37°C with 5% CO2 for one week.  The 
cells were then fixed with a 1:1 mixture of ethanol and glacial acetic acid, stained 
with crystal violet, and the visible cells were counted.   
Results  
The original porphyrin is a dark purple color, while after several hours of 
light irradiation the color is orange.  For the photostability tests, the porphyrins 
degraded faster under light than without the irradiation.  Porphyrins in solution, 
maintained in sealed vials and shielded from light at 4˚C, were found to show no 
decrease in the Soret band for periods exceeding one month (data not shown).  
The TProPyP and TBuPyP were much more stable than the flexible cation 
analogs.  After 24 hours of exposure to visible light, the C3PyP and C4PyP 
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completely degraded (no peak at 416 nm). An example of the C4PyP UV/Vis 
spectrum can be seen in Figure 3.2.  The TProPyP and TBuPyP porphyrins 
maintained their maximum band and color beyond 24 hours of irradiation.  See 
Figure 3.3. 
 
Figure 3.2 The degradation of C4PyP over time*  
 
 
*Measurements were taken at various times of irradiation up to 24 hrs and diluted to 10 µM prior 
to analysis.  All of the porphyrins are marked by four additional peaks (Q bands)to the right of the 
Soret band. These additional signature peaks also degraded with irradiation time while the peaks 
to the left of the Soret for all porphyrins seemed to increase slightly with increased irradiation. The 
bottom spectrum is an expansion of the top spectrum in which the absorbance of the Soret is 
reduced by the time (hours) of exposure to light; in descending order of peak height, t=0 (red), t=1 
(purple), t=2 (light green), t=3 (brown), t=4 (green), and t=24 (black) 
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Figure 3.3 The absorbance of the porphyrin Soret over time* 
 
 
*Measurements were taken at various times of irradiation up to 24 hrs and diluted to 10 µM prior 
to analysis. 
 
From the 1H NMR and MS, it is evident that the C3PyP and C4PyP 
porphyrin, open to the atmosphere, have completely degraded under light and 
new photoproducts were formed.  The TProPyP and TBuPyP showed little 
change in the mass spectrum or 1H NMR after 24hours of light. The 1H NMR of 
the TProPyP and TBuPyP before and after irradiation can be seen in Appendix 2. 
After 24 hours of irradiation, both the 1H NMR (Figures 3.4 and 3.5) and 
MS (Table 3.1) of the C3PyP and C4PyP yielded very different spectra from that 
of the parent compound. 
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Figure 3.4 The 1H NMR of C3PYP before (A) and after (B) 24 hours of irradiation 
(D2O) 
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Figure 3.5 The 1H NMR of C4PYP before (A) and after (B) 24 hours of irradiation 
(D2O) 
A. 
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Table 3.1 The MS peaks of the four porphyrins and their photoproducts*   
Porphyrins Major Peaks M/z 
 ( Relative Abundance) 
Peak Explanations 
C3PyP 
MW 1110.6 
237.87 (100%) Mass 4+ -2Br 
263.13 (100%) Mass 3+ -4Br 
C3 Photoproduct 181.66 (100%) N/A 
379.10 (98%) N/A 
C4PyP 
MW 1166.7 
211.73 (100%) Mass 4+ - 4Br 
309.13 (100%) Mass 3+ - 3Br 
C4 Photoproduct 195.6 (100%) N/A 
TProPyP 
 
 
263.27 (100%) Mass 3+ - 4Br 
394.33 (80%) Mass 2+ - 4Br 
787.40 (80%) Mass 1+ - 4Br 
TPro Photoproduct Same as parent Same as parent 
TBuPyP 281.93 (100%) Mass 3+ - 4Br 
394.27 (100%) Mass 2+ - 4Br -
4(CH2) 
731.40 (80%) Mass 1+ - 4Br - 
8(CH2) 
TBu Photoproduct Same as parent Same as parent 
 
*The TProPyP and TBuPyP showed no change in the mass spectrum after 24hrs of light.  The C3 
and C4 photoproducts could not be determined using MS by the present methods. 
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Reducing the oxygen in the system reduced the porphyrins’ degradation.  
Under anoxic conditions, the C3PyP and C4PyP retained greater than 70% and 
80% of their Soret band respectively in the same time that oxygenated samples 
were completely degraded (no Soret Band).  When comparing the partially and 
fully degraded samples, both methods gave rise to the same photoproducts.  In 
the anoxic system, trace levels of oxygen may have influenced some 
photoproduct formation.  The fact that the porphyrin degradation is inhibited by 
anoxic conditions suggests that oxygen plays a role in the photodegradation of 
the porphyrins. 
While the TProPyP and TBuPyP showed no measurable degradation, the 
toxicity of each of the porphyrin/photoproduct mixtures was measured. A linear 
relationship was found between porphyrin concentration and percent survival, 
and the concentration needed to kill 50% of the cells (LC50) was calculated (See 
Table 3.2).  
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Table 3.2 The LC50s for each of the porphyrins and their photoproductsa 
Porphyrin Average LC50 (µM) 
( Standard deviation) 
C3PyP >500b 
C3Product 6.5 (0.19) 
C4PyP >500b 
C4Product 7.5 (0.01) 
TProPyP 14.6 (0.6) 
TBuPyP 25.1 (5.9) 
 
aThe concentration of porphyrins and photoproducts needed to kill 50% of Chinese Hamster 
Ovary (CHO) cells is shown.  This is an average of three separate trials, each done in duplicate. 
The TProPyP and TBuPyP showed no product formation, and the toxicity of irradiated samples 
was within the stdev of the original samples. 
bThese values are of the highest concentration measured, in which both C3PyP and C4PyP were 
found to be nontoxic. 
 
Discussion 
Photostability and photoproduct formation  
The C3PyP and C4PyP porphyrins degraded much faster than their fixed-
cation analogs.  This is likely due to the pyridinium at the meso position of the 
analogs which can block nucleophilic attack at the most vulnerable position. Also 
the pyridine ring at the meso position of the porphyrins allows for increased 
aromaticity, which could also contribute to its stability. Even still, the C3PyP and 
C4PyP porphyrins took longer than 4 hours to completely degrade.  This is more 
than several times the period required for reasonable inactivation of 
microorganisms 17, 18, 20.   
57 
 
While the C3PyP and C4PyP products were not clearly defined by the MS, 
by monitoring the 1H NMR over various lengths of irradiation it was evident that 
the pyridine is first to fragment (Figures 3.3 and 3.4 A, 7-9 ppm), followed by the 
break in the porphyrin macrocycle (Figures 3.3 and 3.4 A. 9.8 ppm).  Previous 
literature and the present data suggest that the photoproducts consist of oxidized 
pyrrole and dipyrrole derivatives, which are likely accompanied by the 3 and 4 
carbon chains, and some type of pyridinium salt 25.    
There are two types of porphyrin photodegradation 26: one in which the 
chromophore remains intact in some modified state, and the second in which the 
compound is broken into smaller fragments that no longer absorb light in the 
visible region.  While the TBuPyP and TProPyP may have shown some 
degradation, the fact that they maintained their Soret band over 24 hours of 
irradiation may suggest a photoproduct with intact chromophore; however, the 
C3PyP and C4PyP photoproducts are definitely fragmented. 
Toxicity 
With the four porphyrins examined, some general trends were observed. 
The C3PyP and C4PyP were less toxic in their native state (prior to irradiation) 
than their fixed-cation analogs, but had more toxic photoproducts.  The TProPyP 
and TBuPyP, which both showed little degradation over 24 hours, showed little 
difference in toxicity between the parent compounds and the irradiated 
photoproducts.  While the C3PyP and C4PyP and their photoproducts were 
nontoxic at the levels suggested for effective disinfection (1 µM), the fact that the 
photoproducts are more toxic is of some concern.  The data suggest that the 
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photoproducts of these porphyrins could be tens of times more toxic than the 
parent compounds and should be used to assess environmentally safe 
concentrations.  If these products were to accumulate in the drinking water 
system or in the body, they could have adverse effects.  
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Chapter 4: Porphyrin Binding, ROS production, and Subsequent 
Inactivation  
Background 
Recent studies have shown that cationic photosensitizers (PSs), irradiated 
with light, are particularly efficient in the inactivation of non-enveloped viruses as 
well as gram-negative bacteria in aqueous media 1-10.   It is believed that the 
positive charge on cationic PSs help them to better associate with the 
predominantly negatively charged surfaces on target pathogens.  Since the 
diffusion distance of singlet oxygen, the reactive oxygen species involved in PDI, 
is roughly 50 nm 11, bringing the PS in close proximity to the target is imperative 
for the short-lived ROS to reach and damage the target pathogen.   
To date several studies have shown some connection between cationic 
character of the PS and the binding of that PS to gram-negative bacteria 1, 9, 10 12. 
However, in some studies using various cationic PSs, the PS uptake by the cell 
does not fully explain levels of inactivation1, 9, 12.  Some PSs that have a greater 
overall uptake still result in less overall inactivation.  The ultimate location of the 
PS bound to or incorporated into the cell may also play a large role in the 
efficiency of PDI.  PDI from porphyrin association with the outer surface of 
bacteria and viruses could be different from its actual uptake and incorporation 
into the bacterial cell.  If the inactivation is driven by damage to the pathogen’s 
genetic material, then porphyrin uptake is instrumental to PDI; however, if
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oxidation of the pathogen surface (outer membrane, cell wall, capsid, envelope, 
etc.) is the predominate mechanism for PDI, then uptake may be less important.  
Furthermore, PS uptake could feasibly be counterproductive to PDI if the PS is 
altered in the uptake process, shielded from light within the cell, or removed from 
the sites on or near the outer surface that are critical to PDI.  While the rapid 
inactivation of MS2 observed in studies reported in Chapter 2 (nearly 6 logs 
reduction in 1 min) would suggest surface interactions to be the dominant mode 
of action, it is possible that different types of pathogens (bacteria, viruses, 
parasites) will undergo different routes of inactivation by photodynamic 
processes.  
Cationic porphyrins are one group of chromophores that have proven to 
be effective in the inactivation of viral, bacterial, and fungal and parasitic 
pathogens. 1, 7-10, 13-15.  The cationic porphyrins used in previous tests have 
carried fixed positive charges on the periphery of the tetrapyrrole macrocycle. 
Porphyrins with positive charges attached farther from the ring through an 
aliphatic carbon chain have been synthesized to allow the positive charge to 
move more freely and possibly better adapt to the shape and negative charge 
distribution on the surface of target microorganisms.  Porphyrin analogs with the 
positive charge connected at the periphery of the porphyrin macrocycle were also 
synthesized to observe the effects of positive charge position on the binding to 
and subsequent inactivation of E. coli and Salmonella LT2 and their 
corresponding bacteriophages.  The singlet oxygen production was also 
observed, and an attempt was made to distinguish the final localization of 
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porphyrin associated with the target cells.  The porphyrins used in this study can 
be seen in Figure 4.1. 
 
Figure 4.1 The four porphyrins used in this study and their abbreviations 
 
                           Meso-tetrakis (3-[N-pyridiniumyl] propyl) porphyrin 
                               tetrabromide                                                                                                       
 
                Meso-tetrakis (4-[N-pyridiniumyl] butyl) porphyrin 
                                                                        tetrabromide 
 
                            
                         Meso-tetrakis (3-[N-propyl] pyridiuniumyl) porphyrin  
                           tetrabromide 
                 
                  Meso-tetrakis (4-[N-butyl] pyridiniumyl) porphyrin  
                                                                           tetrabromide 
 
Materials and Methods 
Porphyrins 
All porphyrins were synthesized in our laboratory as previously described in 
chapter 3.  
 
N
NH
N
HN
N+
N+
N+N
+
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Microbial Inactivation 
E coli FAmp (ATCC 700891), Salmonella LT2 (ATCC19585), MS2 
(ATCC19585), and PDR-1 (ATCC 700044) were used in the following 
experiments.  The bacterial host, Salmonella LT2 or E. coli FAmp, was 
inoculated into 30 mL of TSB and incubated for 18 hours at 37°C in a shaking 
incubator prior to experimentation.  100 µL of the sample was seeded into 30 mL 
of TSB and incubated for 4 more hours on the day of the experiment.  The 4-hour 
stock was diluted 2 parts PBS to one part stock and used in the bacterial 
inactivation and binding experiments (108-109 cfu/mL).  Undiluted stock was used 
as a host for the bacteriophage inactivation.  5 mL of this dilution was placed into 
a vial with a stir bar and 5 µL of 1mM porphyrin to make a final concentration of 1 
µM. At specific intervals of irradiation with a 300W halogen projector ( 4.72 
mW/cm2), starting from T=0, a 10 µL sample of the solution was removed, diluted 
to a countable range, and transferred onto Petri plates of TSA using top agar 
(TSB with 0.07% Agar); 3 dilutions were plated for each time period.  The agar 
was allowed time to cool and gel; plates were inverted and incubated at 37°C 
with 5% CO2 overnight. Colonies appear as opaque dots upon a clear surface; 
bacterial concentrations were measured as colony forming units (cfu) per mL.  
Controls included samples with porphyrins and test microbes without irradiation, 
top and bottom agar only, and the microbe with irradiation and no porphyrin.  
Test concentrations were compared to those of samples from the same bacterial 
stock before the addition of porphyrin and light to calculate the log reduction of 
bacteria. 
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For bacteriophage inactivation, 600 µl of phage stock (1011 and 1013 
cfu/mL for MS2 and PRD-1 respectively) was added to 12 mL of PBS and 
exposed to the porphyrin and light as described above. This same stock is used 
in later binding experiments.  After 1 min (MS2) and 30 min (PRD-1), the 
samples were diluted and plated with 150 µl of the bacterial host (E coli for MS2 
and Salmonella for PRD-1).  Plaques, which originate from a single virus 
particle’s infection and rupture of a host cell, appear as a clear patch on an 
opaque confluent lawn.  Phage concentrations were measured as plaque forming 
units (pfu) per mL. 
Porphyrin Binding  
This procedure was adapted from a combination of photosensitizer-
bacteria binding studies from previous literature 1, 9, 10.  The Salmonella and E. 
coli stocks described above were quantified using the described pour-plate 
method.  5 µL of each porphyrin (1 mM) was separately added to 5 mL of the 
diluted bacterial solution to achieve 1 µM porphyrin.  After allowing 5 min for 
efficient binding9, four 1 ml aliquots were then placed in 1.5 mL centrifuge tubes 
so that there were four samples for each porphyrin/bacterium combination.  All of 
the samples were then centrifuged at 13,000 g for 5 minutes.  The supernatant 
was removed, and the cells were resuspended by vortexing in 1 mL PBS. The 
porphyrin washing was repeated three times in total.  After the third supernatant 
was removed, the cells were resuspended in 3% sodium dodecyl sulfate (SDS; 3 
g/100 mL DIW).  The fluorescence of two of the samples for each porphyrin was 
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measured immediately, while the other two samples were placed in a sonicator 
for 30 min at room temperature prior to the measurement of fluorescence.  
The binding after sonication was meant to assess the amount of porphyrin 
uptake into the cell.  The series of porphyrin washings should remove the 
porphyrins that are not at least loosely bound to the bacteria.  The 30-minute 
sonication should induce cell lysis and release any porphyrins within the cell. 
To measure porphyrin binding to bacteriophages, a similar method was 
used with the previously-described bacteriophage stock.  An ultra-centrifuge 
equipped with a swinging bucket rotor was used to pellet the virus at 35,000 g for 
3 hours, and the supernatant was removed.  The pellet was resuspended in 5 mL 
of PBS and compared to a 0.25 µM porphyrin sample.  In order to account for all 
of the porphyrin in solution, the fluorescence of both the supernatant and pellet 
resuspension were analyzed as described above and reported as the percent of 
the porphyrin remaining when compared to the original 1 µM concentration. 
Fluorescence Measurement  
All porphyrins in this study yield a maximum emission around 655-660 nm.  
The settings on the spectrofluorimeter (Perkin- Elmer model 650-10S) were as 
follows: PM Gain, Mode and Response were all set to Norm, Scan Speed was 60 
nm/min, recorder speed was 0.5 cm/min. The peak height of each sample was 
compared to calibration curves of the pure porphyins in 3% SDS using the 
relative intensity of the 0.25 µM concentration as a reference point. The C3PyP 
and C4PyP porphyrins were excited at 416 nm, while the TBuPyP and TProPyP 
were excited at 432 nm.  The emission of red fluorescence was recorded from 
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580-780 nm.  Prior to measuring the fluorescence of test samples, a 1µM and 
0.25 µM porphyrin sample were recorded.  The 1 µM sample should yield a 
reading of 90-110% fluorescence (the full length of the graph).  The same 
spectrofluorimeter settings were used to measure the 0.25 µM standard and the 
four test samples for that specific porphyrin.  
Singlet Oxygen Production 
Singlet oxygen production was measured by the reaction with furfuryl 
alcohol (FFA) that forms one major product that can be analyzed by high 
performance liquid chromatography (HPLC) 16.   A 5 mL solution of porphyrin (10 
µM) and FFA (10 µM) in PBS was irradiated using above-described light for 2 
hours.  A 1.5 mL sample was taken, and phenyl 1-1, 2-ethanediol was added as 
an internal standard (10 µM).  The samples were separated and analyzed on a 
Shimadzu HPLC/ UV (LC2010A HT) with RP column (Zorbax, 4.5 mm x 25 cm, 
P.N. 880952.702) with a flow rate of 0.4 mL per min, 70% DIW 30% methanol. 
The samples were quantified by UV/Vis at 219 nm, and the area under the curve 
was integrated using computer software (Shimadzu EZ start version 7.3 SP1, 
Build 13). 
Results 
 Tables 4.1 and 4.2 show the porphyrins’ inactivation of E. coli and 
Salmonella, respectively.  The controls (bacteria with light irradiation in the 
absence of porphyrin, and bacteria and porphyrins in the absence of light) 
yielded concentrations within the 95% confidence intervals of the original test 
bacterial stock (data not shown), which indicates that there is little or no 
69 
 
inactivation due to the light or porphyrin alone.  The 60 minute dark time is a 
rough estimate and may vary due to the time required to plate all light samples 
prior to plating dark samples. 
Table 4.1 Inactivation of E. coli by fixed and flexible cationic porphyrins 
 
Porphyrin 
(1µM) 
Log reduction (Standard Deviation) 
Light  
30 min 
Dark  
60 min 
C3PyP 2.22 (0.16) -0.09 (0.13) 
C4PyP 3.45 (1.22) -0.001 (0.12) 
TProPyP 0.06 (0.09) -0.17 (0.03) 
TBuPyP 1.75 (1.36) 0.023 (0.08) 
 
*These data were obtained from three trials, each using duplicate samples. Standard deviation is 
given in parenthesis. The negative log reduction actually shows an increase in the concentration 
of bacteria. 
 
 
 
Table 4.2 Inactivation of Salmonella by fixed and flexible cationic porphyrins 
 
Porphyrin 
(1µM) 
Log reduction (Standard Deviation) 
Light  
30 min 
Dark  
60 min 
C3PyP 4.08 (0.47) -0.12 (0.05) 
C4PyP 4.37 (0.35) -0.06 (0.06) 
TProPyP 0.09 (0.07) -0.18 (0.07) 
TBuPyP 1.42 (1.84) 0.13 (0.13) 
*These data were obtained from three trials, each using duplicate samples. Standard deviation is 
given in parenthesis. The negative log reduction actually shows an increase in the concentration 
of bacteria. 
 
 
 
Tables 4.3 and 4.4 show the porphyrins’ binding to E. coli and Salmonella.  
From the average concentrations of porphyrin and bacteria from the inactivation 
experiments, the concentration of porphyrin per 108 colony forming units (CFU) 
was calculated.  The TProPyP binding to both E. coli and Salmonella was below 
the limit of detection using the pre-described method. 
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Table 4.3 Porphyrin binding to E. coli* 
 
Porphyrin nmol/10
8
 
CFU 
95%  
Upper-
lower limit 
Sonicated 
nmol/10
8
 
CFU 
 
95%  
Upper-lower 
limit 
Difference in 
sonication 
nmol/CFU 
95%  
Upper-lower 
limit 
C3PyP 0.93 0.57-1.30 0.92 0.50-1.33 -0.02 -0.09-0.06 
C4PyP 1.33 0.24-2.43 1.39 -0.11-2.88 0.05 -0.41-0.51 
TProPyP <MDL - <MDL - - - 
TBuPyP 0.89 0.33-1.46 1.11 0.62-1.59 0.21 0.06-0.37 
 
 *(<MDL is below the method detection limit,which was 2.24 nM for TProPyP, which corresponds 
to 0.448 - 0.224 pmol/108CFU ) Porphyrins and bacteria were centrifuged at 13000 g for 5 min, 
washed three times with PBS, analyzed on spectrofluorimeter and compared to a standard curve.  
Like samples were sonicated for 30 min to separate the membrane-bound porphyrin with that 
incorporated into the cell. Data shown are the average of three trials, each done in duplicate. The 
upper and lower limit that encompasses 95% of the data is shown on the left of the corresponding 
column. 
 
Table 4.4 Porphyrin binding to Salmonella LT2* 
Porphyrin nmol/10
8
 
CFU 
95%  
Upper-
lower limit 
Sonicated 
nmol/10
8
 
CFU 
95%  
Upper-lower 
limit 
Difference in 
sonication 
nmol/108CFU 
95%  
Upper-lower 
limit 
C3PyP 2.14 1.71-2.57 2.54 2.03-3.04 0.40 -0.30-1.09 
C4PyP 1.70 0.98-2.41 2.32 1.19-3.44 0.62 0.19-1.05 
TProPyP <MDL - <MDL - - - 
TBuPyP 2.118 0.25-4.10 2.70 0.14-5.27 0.53 -0.12-1.17 
 
*(<MDL is below the method detection limit,which was 2.24 nM for TProPyP, which corresponds 
to 0.448 - 0.224 pmol/108CFU) Porphyrins  and bacteria were centrifuged at 13000 g for 5min, 
washed three times with PBS, analyzed on spectrofluorimeter and compared to a standard curve.  
Like samples were sonicated for 30 min to separate the membrane bound-porphyrin with that 
incorporated into the cell. Data shown are the average of three trials, each done in duplicate. The 
upper and lower limit that encompasses 95% of the data is shown on the left of the corresponding 
column. 
 
 
In the binding experiments, the porphyrin bound to the surface of the 
bacteria could not be distinguished from that incorporated into the bacteria to a 
level of statistical significance.  The concentration/108 cfu after sonication was 
taken as the most complete representation of porphyrin associated with the 
bacteria, and it was compared to the inactivation of bacteria by these porphyrins.  
From the E. coli and Salmonella binding experiments, the average data for each 
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of the porphyrins was compared and only that of the TProPyP, which showed no 
measurable binding to either bacterium, was found to be significantly different 
from the other porphyrins. Data was analyzed with a paired 2 sided t-test using 
0.05 as the lower limit for rejection of the null hypothesis.  Actual values for the 
paired T test can be seen in Appendix 4 (Table A4.1). 
Figures 4.2 and 4.3 both show the porphyrin binding to MS2 and PRD-1. 
The actual values used to make these graphs can be seen in Appendix 4 (Table 
A4.2).  In Figure 4.2 the amount of porphyrin in the supernatant is shown, while 
in Figure 4.3, the amount present in the viral pellet  is shown to compare 
porphyrin binding to its inactivation of bacteriophages (Tables 4.5 and 4.6).  
 From Figure 4.2, based on the supernatant, the fixed cationic porphyrin 
concentrations were lowered more by centrifugation than were their analogs 
C3PyP and C4PyP.  However, from Figure 4.3, where the resuspended pellet is 
measured, there is conflicting data, which suggest that the C3PyP and C4PyP 
are more bound to the phage than their analogs.  When comparing the C3PyP 
and C4PyP from Figures 4.2 and 4.3, nearly all of the porphyrin added to the 
system is accounted for; however, a less complete recovery of the the TBuPyP 
and TProPyP was acheived.  This porphyrin that is unaccounted for could be due 
to aggregation, which would lower the emitted fluorescence.  From the stability 
experiments in Chapter 3 there was also evidence of porpyrin aggregation ( See 
Appendix 4; Figures A4.1and A4.2) 
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Figure 4.2 The porphyrin binding to bacteriophages MS2 and PRD-1 measured 
via analysis of the supernatant after ultracentrifugation* 
 
 
*Porphyrins (1 µM) and phage (~1010 pfu/mL) were centrifuged at 35000 g for 3 hrs, supernatant 
was analyzed for fluorescence and compared to samples without porphyrin.  
 
 
Figure 4.3 The porphyrin binding to bacteriophages measured via the 
fluorescence of the resuspended pellet after ultra centrifugation*  
 
 
*Porphyrins (1 µM) and phage (~1010 pfu/mL) were centrifuged at 35000 g for 3 hrs, supernatant 
was analyzed for fluorescence and compared to samples without porphyrin. The above is an 
average of three trials, each done in duplicate. On average, 99.2 % (stdev 0.4) of PRD-1 and 
96.3 % (4.33) of MS2 was pelleted. 
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Table 4.5 MS2 inactivation by fixed and flexible cationic porphyrins* 
 
Porphyrin 
(1 µM)  
Log reduction  (Standard Deviation) 
Light (1 min) Dark (20 min) 
C3PyP 5.61 (1.44) 0.48 (0.66) 
C4PyP 5.80 (0.55) 0.94 (0.55) 
TProPyP 5.57 (1.07) 1.84 (0.93) 
TBuPyP 5.45 (2.14) 2.35 (0.68) 
 
*Porphyrins and MS2 were irradiated (4.72 mW/cm2) or left in the dark before plating and 
overnight incubation.  Reductions are with respect to the MS2 stock prior to the addition of 
porphyrin. The above is an average of three trials, each done in duplicate. Standard deviation is 
shown in parenthesis.  
 
 
Table 4.6 PRD-1 Inactivation by fixed and flexible cationic porphyrins* 
 
Porphyrin 
(1 µM) 
Log reduction  of PRD-1 (Standard Deviation) 
Light (30 min) Dark (60 min) 
C3PyP 0.12 (0.19) 0.13 (0.10) 
C4PyP 0.15 (0.01) 0.07 (0.21) 
TProPyP 0.19 (0.07) 0.31 (0.15) 
TBuPyP 0.07 (0.09) 0.13 (0.01) 
 
*Porphyrins and PRD-1 were irradiated (4.72mW/cm2) or left in dark for before plating and 
overnight incubation.  Reductions are with respect to the PRD-1 stock prior to the addition of 
porphyrin. The above is an average of three trials, each done in duplicate. Standard deviation is 
shown in parenthesis.  
 
Figures 4.4 and 4.5 show the measurements of singlet oxygen production. 
A sample chromatogram from the HPLC can be seen in Appendix 5. Figure 4.4 
shows the production of the major product of FFA and singlet oxygen, while 
Figure 4.5 shows the FFA remaining, after 2 hrs of irradiation with the porphyrin.  
In three of four trials, the TProPyP and the TBuPyP produced more singlet 
oxygen than their analogs (Figure 4.4).  Figure 4.5 supports the above with 
measurements of the FFA residual. In all four trials, TProPyP and TBuPyP show 
the least amount of FFA after irradiation when compared to control samples 
without PS.  If more FFA is degraded by a specific porphyrin, then less FFA 
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should be remaining.  So porphyrins with the least FFA after irradiation will have 
produced larger amounts of singlet oxygen. 
 
Figure 4.4 Measurement of singlet oxygen- furfuryl alcohol (FFA) product* 
 
 
*Porphyrin (10 µM) and FFA (10 µM) were irradiated (4.72mW/cm2) for 2 hrs, internal standard 
was added, and the samples were analyzed via HPLC.  The integration of the area under the 
peak of the FFA-singlet oxygen product was compared to that of the internal standard. 
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Figure 4.5 Measurement of furfuryl alcohol residual* 
 
 
*Porphyrin (10 µM) and FFA (10 µM) were irradiated (4.72mW/cm2) for 2 hrs, internal standard 
was added, and the samples were analyzed via HPLC.  The integration of the area under the 
peak of the FFA with porphyrin was compared to controls with no porphyrin added. 
 
The average data from the singlet oxygen measurements from each 
porphyrin were also compared with a paired 2 sided t-test using 0.05 as the lower 
limit for rejection of the null hypothesis.  When analyzing the FFA-singlet oxygen 
product there was no statistically significant difference in that produced by any of 
the porphyrins; however, the measurement of the FFA residual showed that the 
C3PyP and C4PyP had a significantly more FFA residual than their fixed cation 
counterparts, which is indicative of less singlet oxygen production.   
Discussion 
 The purpose of these experiments was to better understand the effect of 
the cation attachment and flexibility on porphyrin association with and 
subsequent inactivation of target microorganisms (Specific Aim 4). The C3PyP 
and C4PyP both showed greater binding to and inactivation of the test bacteria 
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than did their analogs TProPyP and TBuPyP.  The general trends in porphyrin 
binding and bacterial inactivation are as follows: 
Binding to E. coli C4PyP ~ C3PyP ~ TBuPyP >> TProPyP 
Inactivation of E. coli C4PyP > C3PyP >TBuPyP >>TProPyP 
Binding to Salmonella TBuPyP ~ C3PyP ~ C4PyP >>TProPyP 
Inactivation of Salmonella C4PyP ≥C3PyP >>>TBuPyP=TProPyP  
In general the porphyrins with the most binding to the bacteria showed the 
greatest inactivation. With the Salmonella, the C3PyP and C4PyP yielded very 
close inactivation as well as binding. 
 Sonication was shown to increase the concentration of the C4PyP and the 
TBuPyP more than the C3PyP and TProPyP.  In the E. coli experiment the 
TBuPyP had nearly the same amount of total bound porphyrin as the C3PyP, but 
a larger portion of the TBuPyP was incorporated into the cell.  The C3PyP still 
gave a greater inactivation of E. coli than the TBuPyP.  This shows that increase 
in porphyrin uptake into the cell does not necessarily increase the potential for 
inactivation, and it in fact may be negatively correlated with inactivation. 
 In general the fixed and flexible cationic porphyrins gave a similar yield of 
singlet oxygen, but exhibited markedly different degrees of binding to the test 
bacteria.  The present data suggest that closer binding to or association with 
target pathogens is more important than generation of singlet oxygen in 
determining the efficiency of PDI for bacteria.  Furthermore the amount of 
porphyrin incorporated into the cell seemed to have a negative association with 
the efficiency of PDI.  The latter finding suggests that PDI of bacteria targets the 
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cellular membranes rather than its genetic material.  This finding has been both 
supported11 and opposed17 in previous literature.  
Viral inactivation was not well correlated to porphyrin binding or singlet 
oxygen production.  All porphyrins rapidly inactivated MS2 (greater than 6 logs 
reduction in 1 min) and showed little activity against PRD-1 (all less than 0.2 log 
reduction in 30 min).  This low efficiency of PRD-1 inactivation occurred despite 
the fact that all of the porphyrins, in general, bound more readily to PRD-1 than 
MS2.  For the bacteria, binding and inactivation increased with the flexible 
cationic porphyrins; however, for the viruses, the fixed and flexible cationic 
porphyrins gave similar binding and inactivation.  There seems to be very 
different mechanisms for porphyrin inactivation of bacteria and viruses.  There 
were also large disparities in the inactivation of MS2 and PRD-1 by PDI; the 
greatest difference between the two test viruses is their genetic material, ssRNA 
and dsDNA, for MS2 and PRD-1 respectively.  This major difference suggests 
that the PDI of viruses could be largely dependent on the genetic material of the 
target pathogen.   
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Chapter 5: Porphyrin Activation at Wavelengths of Minor Absorbance 
Background 
To date, investigation and application of photosensitizers (PSs) have 
largely focused on the development of cancer treatments.  The resulting 
knowledge is often relevant to photodynamic inactivation (PDI).  Furthermore, 
synthetic porphyrins were originally developed for photodynamic therapy (PDT), 
an approved treatment for several cancers1-5, and they have more recently been 
applied to the disinfection of blood products6-10.   
In most literature PSs are excited at their maximum absorbance (λmax) to 
achieve the most efficient inactivation.  Nevertheless, porphyrins have 
absorbances at longer wavelengths than the Soret that are still at energies 
capable of generating singlet oxygen.  Excitation at these other wavelengths 
could be preferred in systems where a deeper penetration of light is required, or 
where a specific type of light is already being used in other processes.  Our 
porphyrins have a maximum absorbance at 411-430 nm, but have four low 
extinction Q band absorbances between 510 and 650 nm.  Activating porphyrins 
with longer wavelengths of light could be essential for penetrating various media 
such as turbid solutions and tissues.  Longer wavelength light can offer deeper 
penetration and porphyrin activation in aqueous media that may block out the 
porphyrin Soret.  While drinking water has little turbidity at the disinfection stage, 
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wastewater can be turbid.  The porphyrins in this study also absorb light in the 
UV range (See Figure 5.1); thus, acceptable levels of singlet oxygen generation 
at wavelengths with low extinction coefficients would also prove that these 
porphyrins could be used in conjunction with UV disinfection.  The efficacy of 
porphyrin inactivation of MS2 and the singlet oxygen production were measured 
using longer wavelengths of light than that of the Soret.  
Materials and Methods 
Porphyrin Inactivation of MS2 
 The inactivation of MS2 incorporated the same experimental setup as 
described in Chapter 4 with the addition of a yellow light filter that blocked all 
wavelengths below 450 nm, which encompasses the porphyrin Soret (See Figure 
5.1).  Porphyrins were irradiated for 5 minutes. 
Separately, the inactivation of MS2 (1 mL) by 1 µM C4PyP (the most 
effective porphyrin in the inactivation of MS2) at 650 nm using a 
spectrofluorimeter (Perkin- Elmer model 650-10S) was measured.  The light 
intensity of the spectrofluorimeter was ~15 µW/cm2, which is less than 1/300 the 
intensity as that in the test with the light filter described above (4.72 mW/cm2).                                                                   
Measurement of Singlet Oxygen  
  To measure the singlet oxygen, some amendments were made to the 
literature-based procedure described in Chapter 4.  In PBS buffer 2 mL 10 µM 
porphyrin and 100 µM FFA was irradiated by the pre-described light and filter for 
5 min.  An internal standard (IS), phenyl 1-1, 2-ethanediol (100 µM), was added 
 prior to analysis (Shimadzu HPLC, RP column, flow rate 0.2 mL/min, 70% DIW, 
30% methanol). 
Figure 5.1 C4PyP absorbance (red) compared to filter light absorbance (blue).*  
                                                                                                                             
 
*Above is the UV-visible spectrum of 10 µM C4 PyP in 3% SDS (red) shielded by a transparent 
yellow filter (blue). The full spectrum can be seen on the left, while an expansion of the longer 
wavelengths can be seen on the right.         
 
Results  
Inactivation 
Inactivation of MS2 by all four porphyrins (1µM in PBS) in both the 
presence and absence of light was examined (Table 5.1). The average log 
reduction of MS2 in light and dark samples was calculated. In light, all porphyrins 
yielded a similar inactivation of MS2. The
porphyrins were most efficient. TBuPyP showed the highest degree of 
inactivation in the presence and absence of light with almost a 4
Unlike the other porphyrins that had a small (~0.3 log) reduction withou
TBuPyP achieved nearly 90% reduction in each dark trial. TProPyP was the least 
effective porphyrin under the longer wavelength light. 
 
 
 
 
 
←
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Table 5.1 MS2 inactivation by porphyrins in PBS with filtered light and in dark* 
 
  
Porphyrin 
(1µM) 
Log inactivation (Standard Deviation) 
Light  
5 min  
Dark  
~15 min  
Log Inactivation  
Light – Dark 
C3PyP 2.90 (0.50) 0.28 (0.33) 2.67 
C4PyP 3.16 (0.24) 0.26 (0.02) 2.91 
TBuPyP 3.90 (0.54) 0.93 (0.13) 2.98 
TProPyP 2.82 (0.49) 0.32 (0.37) 2.50 
 
*Porphyrins and MS2 were irradiated (4.72 mW/cm2) while shielded with a light filter. Log 
reductions are relative to MS2 titers in the absence of porphyrin. Above data is the average of 
three trials, each with duplicate samples.  
 
Since inactivation of MS2 was observed in the dark, the difference 
between light and dark inactivation was calculated (Table 5.1, last column). This 
difference allowed for a separation of the inactivation due to PDI from the 
inactivation due to the dark toxicity of the porphyrins.  By accounting for the dark 
toxicity of the porphyrins, the variation in inactivation between the porphyrins was 
reduced.  Despite differences in cation position, each of the porphyrins gave 
similar inactivation of MS2.  
 The duration of long-wavelength light exposure to reach a 3-log reduction 
was compared to that of the same porphyrins against MS2 without a light filter 
(Table 5.2).  The time needed for a 3-log reduction was calculated with the 
assumption that there is a linear relationship between the inactivation of MS2 and 
the time of light exposure.  Evidence of linear inactivation can be seen in 
Appendix 6.  It is evident that longer irradiation times are needed for the 
porphyrins to inactivate equal amounts of MS2 without irradiation of the Soret.  It 
took roughly 8 to 13 times as long for porphyrins to reach a 3-log reduction with 
the light filter when compared to the unobstructed light.  The ratio between time 
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with and without the light filter is comparable to the difference in porphyrin 
activation (based on absorbance).   
 
Table 5.2 Time needed to reach 3-log MS2 reductions with and without light 
filter* 
 
Porphyrin 
 
(1µM) 
Estimation of 3 Log 
reduction time (min) 
Ratio        
(with filter: 
without 
filter)  
Absorbance 
Ratio (Q 
band: 
Soret) 
without light  
filter  
with light 
filter  
C3PyP 0.4  5.2  12.4  15.5 
C4PyP 0.5 4.7  10.4  17.3 
TBuPyP 0.5  3.9 7.8  10.0 
TProPyP 0.4 5.3 13.3  10.7 
 
*Linear estimations of the duration of a 3 log inactivation of MS2 by porphyrins with and without 
the light filter using data from tables 4.3 and 5.1. The absorbance ratio is the peak height of the 
largest absorbance not blocked by the filter (minor) compared to that of the Soret. 
 
Separately, the inactivation of MS2 by C4PyP was measured at one 
specific wavelength of excitation.  Since the C4PyP has a minor absorbance at a 
longer wavelength than the other porphyrins, and it had the most efficient 
inactivation of MS2, the inactivation of MS2 via the longest wavelength was 
measured (645 nm; see Figure 5.1) to support the above data.  While the singlet 
oxygen produced under these conditions was below the method detection limit  
(MDL),  which was 2% the area under the curve of the internal standard, it was 
observed that, under the 645 nm light, the C4PyP was capable of inactivating 
MS2 to a level of statistical significance (see Table 5.3). 
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Table 5.3 C4PyP inactivation of MS2 at 645 nm* 
 
Test Solution Percent survival % 
(standard deviation) 
95% upper-lower 
limit 
Dark  41.4 (22.7) 
 
63.6 -19.1 
Light 6.2 (5.0) 
 
11.1 -1.3 
 
*MS2 and 1µM C4PyP was exposed to 645 nm light for 30 min and compared to the original MS2 
stock. The dark exposure consisted of 1µM C4PyP and MS2 placed in the spectrofluorimeter for 
30 min without light. 
 
Measurement of Singlet Oxygen 
 There was a malfunction in the data acquisition of the HPLC, likely due to 
column fouling, that consistently gave duplicate peaks for pure compounds.  
While these additional peaks prohibited the quantification of relative amounts of 
singlet oxygen produced by each porphyrin under filtered light, the proper 
controls offered proof that each of the porphyrins produced a measurable amount 
of singlet oxygen (See Figures 5.2-5.9). 
 
 
Figure 5.2 Control chromatogram of TProPyP (10µM), FFA (100µM) and IS 
(100µM) without light 
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Figure 5.3 Chromatogram of TProPyP (10µM), FFA (100µM) and IS (100µM) 
with 5 minutes exposure to filtered light 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Chromatogram of overlay of figures 5.2 and 5.3*   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
*Notice the new product peaks around 15 to 20 minutes in the sample with light (blue) as well as 
an overall reduction in the FFA. 
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Figure 5.5 Control chromatogram of FFA and IS with 5 minutes exposure to 
projector light.  
 
 
 
 
 
 
 
 
 
Figure 5.6 Control chromatogram FFA and IS without light. 
 
 
 
 
 
 
 
Figure 5.7 Control Chromatogram of TProPyP and IS with 5 minutes exposure to 
projector light. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.8 Chromatogram of overlay of graphs 5.5, 5.6, and 5.7*
 
 
 
 
 
 
 
*The identical control graphs 5.5 and 5.6 show that the IS and FFA do not react under light and 
that the presence of porphyrins is needed to produce the singlet oxygen 
5.7 shows that the porphyrin does not react with the IS under
 
The appropriate cont
and FFA was formed only by the presence of porphyrin, FFA, and light.  The FFA 
did not react with the IS or light to produce any peaks in the product region (13
23 min).  Furthermore, the IS did not react 
produce any peaks in the product region. 
Discussion 
The porphyrins’ efficiency with filtered light was compared to the free 
chlorine disinfection of MS2 (Table 5.4).  At similar temperatures and turbidity, 
the time for a 4-log reduction in the presence of porphyrin was estimated based 
on an assumption of linear inactivation over time.  The CT constant, which is the 
product of the concentration (mg/L) of the disinfectant and the time needed (min) 
for specific levels of inactivation, was compared for equal amounts of 
inactivation.  For an equal level of inactivation, the cationic porphyrins have a 
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– FFA product. Graph 
 light. 
rols have shown that the product of singlet oxygen 
with the porphyrin or singlet oxygen to 
 
-
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much lower CT constant than that of free chlorine, which means that that these 
porphyrins are much more effective against MS2 with the filtered light and less 
efficient PDI. 
 
Table 5.4 Comparison of our study to previous literature on chlorine disinfection 
of MS2  
  
System Characteristics  Free Chlorine (Chaidez et. al.)  C3PyP  TProPyP  C4PyP  TBuPyP  
Microbe  MS2  MS2  MS2  MS2  MS2  
Disinfectant  
Concentration  100 mg/L  1.11 mg/L  1.11 mg/L  1.17 mg/L  1.17 mg/L  
Temperature (°C)  25°C  25°C  25°C  25°C  25°C  
Nephelometric Turbidity 
Units (NTU) 2  0.23  0.23  0.23  0.23  
~ Log Reduction  4  4  4 4  4  
Contact Time (min.)  2  6.9  7.1 6.3  5.1  
CT Constant [(mg. 
min/L)]  200  7.7 7.9 7.4 6.0 
 
 
The data from these experiments supports that from the previous chapters 
in that the porphyrins with the more rigid cation attachment proved to be more 
toxic without irradiation, and all the porphyrins gave a similar inactivation of MS2.  
The porphyrin inactivation with the light filter proved feasible the application of 
these porphyrins and other PS with light outside of their maximum absorbance; 
this was supported by the observed production of singlet oxygen.  Even at the 
highest wavelength, with a lower light intensity that yielded a singlet oxygen 
production below the method detection limit, significant inactivation of MS2 was 
observed.  In general, if a PS has an absorbance with a low extinction coefficient 
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of a desired wavelength, then it should be considered for PDI or PDT even if the 
absorbance is not the λmax. 
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Chapter 6: Conclusion 
 
Review of Specific Aims 
The goal of this research was to develop a series of flexible cationic 
porphyrins as disinfectants for aqueous solutions.  The preliminary studies have 
shown that the flexible cationic porphyrins are potentially more effective than 
disinfection by free chlorine.   In order for this group of porphyrins to become 
useful in a public health setting, a series of these porphyrins was characterized 
for use in water treatment.  Specific questions were answered so as to better 
understand the porphyrins’ stability in storage and in use, native state toxicity, 
and other factors that influence PDI efficiency.    
Analogs to the above-described porphyrins were synthesized with the 
cation positioned at the more-rigid periphery of the porphyrin macrocycle to 
observe the effects of cation position on porphyrin stability and toxicity, and 
porphyrin binding to and inactivation of model pathogens relevant to PDI.  
The present study offers a proof of concept of these porphyrins’ 
applicability to the disinfection of water and other aqueous media.  The following 
questions were the focus of this research: 
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1) What is the optimum chain length for porphyrin inactivation of model 
pathogens? 
The cationic porphyrins used in previous tests have carried charges at 
fixed distances from the tetrapyrrole macrocycle.  Porphyrins with a flexible alkyl-
cation linkage were synthesized to adapt to the various negative charge 
distributions on the surface of pathogens.  The inactivation of E. coli by these 
porphyrins was measured.  The most efficient porphyrins were found to be those 
with a propyl and butyl linkage (C3PyP and C4PyP).  This led to the synthesis of 
rigid cation analogs (TProPyP and TBuPyP) in order to specifically observe the 
effect of the more flexible cation position on porphyrin stability, toxicity, binding 
and inactivation. 
2) What is the stability of the porphyrins under various conditions that 
simulate likely real-life use?   
There is now a better understanding of how long the porphyrin maintains 
its integrity when irradiated as well as in the absence of light.  The photostability 
of four porphyrins with different cation attachment was examined, and the 
degradation of these porphyrins was confirmed using 1H NMR and UV/Vis and 
mass spectrometry. 
The C3PyP and C4PyP porphyrins degraded much faster than their 
analogs.  This is more than likely due to the pyridinium at the meso position of 
the analogs which can sterically block nucleophilic attack at the most vulnerable 
position.  The pyridine ring at the meso position of the porphyrins also allows for 
increased aromaticity, which could contribute to its stability. Even still the C3PyP 
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and C4PyP porphyrins took longer than 4 hours to completely degrade.  This is 
more than several times the period required for reasonable inactivation of 
microorganisms. 
  By monitoring the 1H NMR over various lengths of irradiation, it was 
observed that the pyridine is first to fragment, followed by the break in the 
porphyrin macrocycle.  Although the C3PyP and C4PyP products were not fully 
defined by the 1H NMR and MS, the present observations were in concordance 
with previous literature that suggests the photoproducts consist of oxidized 
pyrrole and dipyrrole derivatives, likely accompanied by the aliphatic chain and a 
pyridinium salt.    
Reducing the oxygen in the system reduced porphyrin degradation.  
Comparison of the partially and fully degraded samples indicated that the initially 
formed photoproducts were stable over time.  The fact that the porphyrin 
degradation is inhibited by anoxic conditions supports the theory that oxygen is 
involved in the photodegradation. 
3) What is the potential toxicity of the porphyrins and their degradation 
products?  
The toxicity of the parent porphyrins and the photoproducts to model 
mammalian cells was measured.  With the four porphyrins examined, some 
general trends were observed.  The C3PyP and C4PyP were less toxic than their 
fixed-cation analogs, but had more toxic photoproducts.  The TProPyP and 
TBuPyP, both of which showed little degradation over 24 hours, showed little 
difference in toxicity between the parent compounds and the irradiated sample.  
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Although the C3PyP and C4PyP and their photoproducts were nontoxic at the 
levels suggested for effective disinfection (1µM), the fact that the photoproducts 
are more toxic is of some concern.  The present data suggests that the 
photoproducts of these porphyrins could be tens of times more toxic than the 
parent compounds and should be taken into account in risk assessment. 
4) How does the attachment of the cation to the porphyrin periphery affect 
the binding to and subsequent inactivation of specific bacteria and 
viruses?   
The PDI of model pathogens by these porphyrins and their fixed cation 
analogs was measured to better understand the effect of the mobile cation 
position.  The amount of porphyrin that is bound to the target microbe and the 
singlet oxygen production was also examined.  To meet this aim, a method was 
developed to observe the viral binding of porphyrins, which has not been 
previously documented.  The porphyrins with the more flexible cation linkage 
offered greater attachment to bacteria; the porphyrins with the most binding to 
the bacteria showed the greatest inactivation.  The bacterial binding had more 
influence on inactivation than that of the virus. 
It has been shown that closer binding to or association with target 
pathogens is more important than generation of singlet oxygen in determining the 
efficiency of PDI of bacteria. Of the porphyrin that was closely associated with or 
bound to bacteria, that located at the outer membrane was better correlated with 
inactivation than the porphyrin that was incorporated into the cell.  Furthermore, 
the amount of porphyrin incorporated into the cell seemed to have a negative 
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association with the efficiency of PDI.  The latter finding suggests that PDI of 
bacteria targets the cellular membranes rather than its genetic material.  This 
finding has been both supported11 and opposed26 in previous literature.  
Overall, viral inactivation was not well correlated to porphyrin binding or 
singlet oxygen production.  All porphyrins gave a rapid inactivation of MS2, but 
showed little activity against PRD-1.  This large reduction in the inactivation of 
PRD-1 occurred despite the fact that all of the porphyrins had greater binding to 
PRD-1 than MS2.  This shows that there are different mechanisms for porphyrin 
inactivation of bacteria and viruses. There were large disparities in the 
inactivation of MS2 and PRD-1 by PDI; the greatest difference between these 
two test viruses is their genetic material, ssRNA and dsDNA, for MS2 and PRD-1 
respectively.  While this major difference suggests that PDI of viruses could be 
largely dependent on the genetic material of the target pathogen, both RNA and 
DNA viruses have been shown to be susceptible to PDI (See Appendix 1).   
5) Will long-wavelength light excite the porphyrins to a level effective in 
disinfection?   
 Porphyrins have a maximum absorbance at 411-430 nm, but have four 
low extinction Q-band absorbances between 510 and 650 nm.  If longer 
wavelength light can be used to generate singlet oxygen and a biocidal effect, 
these porphyrins could be used for a wider variety of settings that require deeper 
light penetration of media.  Furthermore, PDI at these longer wavelengths also 
suggests that these porphyrins could also be used to improve disinfection by UV 
light.  The porphyrins used in this study actually have a greater absorbance of 
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UV light than the longer wavelengths between 510 and 650 nm; thus, we can 
assume that they would undergo greater excitation and have a more efficient PDI 
under UV light than with the longer wavelengths.  Even with the filtered light and 
less excitation, the cationic porphyrins in this study have proven to be more 
effective than chlorine (from previous literature) in the inactivation of MS2. 
  The inactivation of MS2 by the porphyrins and filtered light proved 
feasible the application of these porphyrins and other PSs with light outside of 
their maximum absorbance; this was supported by the observed production of 
singlet oxygen. Even at the longest wavelength, with a light intensity that 
produced singlet oxygen below the threshold for measurement, we observed 
significant inactivation of MS2.  In general, even if a PS has weakly absorbing 
bands of a desired wavelength, it should be considered for PDI or PDT even if 
the wavelength is not the λmax.  
Future Implications 
 The effect of the flexible cation linkage is applicable to all synthetic PSs 
that are applied to the disinfection of water.  Since the pathogens most resistant 
to modern drinking water treatment have a net negative charge, this flexible 
linkage could potentially improve the PDI of various types of PSs. 
From the vast difference in porphyrin PDI of MS2 and PRD-1, it is evident 
that all viruses are not equally susceptible to PDI, and target viral pathogens 
should be independently examined with the PS of choice to predict the efficiency 
of PDI.  
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 As an added measure of disinfection, the feasibility of PDI should be 
examined in various stages of drinking water treatment.  Since all water 
treatment facilities are not the same, it is likely that PDI will be more applicable 
and economical in specific settings.  The porphyrins’ range of absorbance and 
efficiency in turbid media could allow for PDI at various stages of the disinfection 
process. These PSs would be especially economical in those stages that involve 
exposure to sun or UV light, or in those where natural irradiation could be 
achieved.    
Due to the increased toxicity of the porphyrin photoproducts, an 
investigation of strategies for the removal of porphyrins and other PSs is 
important; however, it is likely that these compounds could be used effectively at 
levels that would not warrant adverse health effects (no toxicity was observed at 
1µM porphyrin which was adequate for the PDI of E. coli, Salmonella, and MS2). 
 The present work is a proof of concept for the use of porphyrins with a 
flexible cationic linkage to improve PDI. The porphyrins’ absolute lifetime and PDI 
in environmental samples are areas that need to be further developed. 
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Appendix1. A list of previously documented PDI of frank and model 
pathogens by various PSs 
The following list of frank and model pathogens that have been used in studies 
with photosensitizers and light.  All have been used in inactivation studies.  Some 
PSs below have been used in binding studies with bacteria.  Inactivation studies 
varied by the photosensitizer used, the light source, and the duration of 
exposure. A list of references for the chart follows. 
Table A1.1 A list of previously documented PDI of frank and model pathogens  
Name, strain Photosensitizer Inactivation (log 
inactivation, 
duration, PS 
concentration, light 
type, intensity, 
wavelength, etc.) 
Gram 
reaction; 
Enveloped or 
non-
enveloped   
genetics Size, shape, 
other 
characteristics 
Ref 
Bacteria 
 
Staphylococcus 
aureus MRSA 
110 
Fixed cationic 
Porphyrins, 
Various dyes 
7 logs, 20 min,1µM, 
100 mW/cm2 400-
800 nm 
 
6 logs, 5-20 j/cm2, 1-
10 µM 
50-400 mW/cm2 
 
Gram + Circular 
DNA 
nucleoid 
(CDNA) 
Spherical/ 
clustered, 0.5-
>1µm 
12
 
Enterococcus 
seriolicida 
Porphyrins w/ 
varying # of cations , 
   
Zinc pyridinium 
phthalocyanines 
 
 
6 logs, 5 min, 8 µM, 6 
mW/cm2 
 
3.5 logs, 15 min,10 
µg/mL, 1 mW/cm2, 
600-700 nm 
Gram + (CDNA) Marine bacteria 34
  
Enterococcus 
faecalis 
ATCC29212 
Meso-phenyl 
porphyrins w/ 
varying # of cations 
iodide- 
7 logs, 15 min, 1µM 
4 mW/cm2, white, 
(64.8 J/cm2) 
Gram + (CDNA) Commensal 
bacteria 
spherical 
5
 
Listeria 
monocytogenes 
LM353 
TMPyP 6 logs, 10 min, 5 µM, 
7.6 mW/cm2, 660 nm 
 
Gram + (CDNA)  6
 
Fecal 
Streptococci 
TMPyP 4 logs, 5 µM, 60 min, 
19 mW/cm2 
Gram + (CDNA) Spherical, 
includes six 
species 
7
 
E. coli ATCC 
13706 
Meso-phenyl 
porphyrins w/ 
varying # of cations 
iodide- 
7 logs, 25 min,1 µM 
4 mW/cm2, white, 
(64.8 J/cm2) 
Gram - (CDNA) Rod shaped 5
 
E. coli O4 Fixed cationic 
Porphyrins, 
 
4 logs, 20 min, 1 µM, 
100 mW/cm2 400-
800 nm 
 
4 logs, 15 min, 1µM, 
19 mW/cm2 
Gram - (CDNA) Rod shaped 
2µm by 0.5µm 
1, 8,
 
9,
 
10
 
100 
 
6 logs, 15 min, 8µm, 
6 mW/cm2 
 
5 logs, 30 min,10 µM, 
150 mW/cm2, white 
 
E. coli JM-109  2 logs, 20 min, 4-11 
µM, 9 J/cm2, 407 nm 
blue 
Gram - (CDNA)  11
 
E. coli ATCC 
25922 
Toluene blue, Rose 
Bengal bound to 
poly lysine 
 
6 logs, 0.3 J/cm2, 
1µM 
50-400 mW/cm2 
 
 
Gram - (CDNA) Poly lysine 
bound 
porphyrin 
2
 
E. coli EC7 Porphyrins w/ 
varying # of cations    
4 logs, 20 min, 1µM, 
90 mW/cm2 360-800 
nm 
 
6 logs, 10 µM, 30 
min, 90 mW/cm2 
 
Gram - (CDNA)  12, 13
 
E. coli WP2 
TM9 
TMPyP 5 logs, 30 min,10 µM 
150 mW/cm2, white 
Gram -  uvrA- and trp-, 
Ampicillin 
resistant 
10
 
E. coli TG1 TMPyP 5logs,30min,10 µM 
150mW/cm2, white 
Gram - (CDNA) Transfected 
with plasmid 
pUC19 
 
10
 
E. coli BS-1 TMPyP -5logs,30min,10 µM 
150mW/cm2, white 
Gram - (CDNA) hcr- 
 
10
 
E. coli DH5 TMPyP -
6logs,60min,10µg/mL 
1mW/cm2,600-
700nm 
Gram - (CDNA)  4
 
E. coli O157:H7 TMPyP -6logs,60min,5 µM , 
7.6mW/cm, 660 nm 
Gram - (CDNA)  6
 
Pseudomonas 
aeruginosa 
strain 12718 
Zinc pyridinium 
phthalocyanines 
-
4logs,60min,10µg/mL 
1mW/cm2,600-
700nm 
Gram - (CDNA)  4
 
Vibrio 
anguillarum 
Porphyrins w/ 
varying # of cations    
-6logs,30min,8µM, 6 
mW/cm2 
 
Gram - (CDNA) Marine bacteria 3
 
E. coli C3000 Tetra cationic 
porphyrins w/ 
flexible cation 
-4 logs,30min,1µM, 
4.72mW/cm2 
Gram - (CDNA)  Present 
study 
E. coli F Amp Tetra cationic 
porphyrins w/ 
flexible cation 
-4 logs,30min,1µM, 
4.72mW/cm2 
Gram - (CDNA)  Present 
study 
Salmonella LT2 Tetra cationic 
porphyrins w/ 
flexible cation 
-5 logs,30min,1µM, 
4.72mW/cm2 
Gram - (CDNA)  Present 
study 
Fecal Coliforms Tri-methyl phenyl 
substituted 
porphyrins, 
TMPyP 
-3 logs, 5 µM, 270 
min, 9 mW/cm2 
-5 logs, 5 µM, 240 
min,19 mW/cm2 
Gram - (CDNA)  7, 14
 
Viruses 
Vesticular 
Stomatitus virus 
Various dyes, 
Methyl Blue 
 
Benzo-porphyrin 
derivatives 
-4-5logs, 25µM, 
240kJ/m2, 
100mW/cm2 red 
 
-3logs, 2 µM, 0.69 
J/cm2, 3.17mW/cm2 
LED 
 
-2logs, 4 µg/mL, 20 
J/cm2, red 600-
700nm 
enveloped ssRNA 
 (-) 
Helical rod 
shaped 
15,16,17
 
101 
 
HIV Type 1 IIIB Natural and 
synthetic 
metalatedporphyrins 
(tetraphenyl 
sulphonate 
101erive, 
Methyl Blue derive 
 
Di hematoporphyrin 
Ether 
<-2 log 50 µg/mL, 
dark 
 
>-3logs, 2 µM, 0.69 
J/cm2, 3.17mW/cm2 
LED 
 
 
-70%, 10 µg/mL, 5 
J/cm2,  
enveloped ssRNA 
(+) 
PDI targeted 
Env proteins 
18,16,19
 
Herpes HSV-1 
ATCC 539-VR 
Merocyanine 540 
 
Benzo-porphyrin 
derivatives 
-6logs, 10min, 15 
µg/mL, 7mW/cm2 
fluorescent  
 
-6logs, 20J/cm2, 4 
µM, 0.001mW/cm2  
 
enveloped dsDNA 120-200nm, 
icosahedral 
Virion PI 4.9 
nucleocapsid 
4.1 
20,19
 
Hepatitis A 
HAV  
Fixed porphyrin 
TMPyP 
-4logs, 10 µM, 
10min, 2.2mW/cm2 
365nm 
 
nonenveloped ssRNA 27-32nm 21
 
T4-like phage Meso-phenyl 
porphyrins w/ 
varying # of cations 
iodide- 
-7logs, 5µM, 180min 
4mW/cm2, white 
nonenveloped Linear 
dsDNA 
Special DNA 
repair 
mechanisms,  
infects EC 
O157:H7, 
90nm x 200nm 
22
 
T7 Phage Glycosylated tetra 
phenyl porphyrin 
-6logs, 2 µM, 
80mW/cm2, 
0.2KJ/cm2, 400-
650nm 
 
 
nonenveloped DNA PI 5.4-6.6 23
 
Lambda phage TMPyP 0.7 logs, 660 mn nonenveloped Linear ds 
DNA 
Icosahedral, 
Ecoli host, 
64nm x 150nm 
24
 
Poliovirus Methylene Blue -2.5 logs, 5 min, 
2mW/cm2 , 670nm, 
13 µM, pH10 
 
nonenveloped ssRNA 
(+) 
30nm diameter 
icosahedral, PI 
8.2 
25
 
Feline 
Leukemia Virus 
Benzo-porphyrin 
derivatives 
-1log, 0.1 µg/mL, 20 
J/cm2, red 600-
700nm 
enveloped ssRNA Retrovirus 
+mRNA  
MS2 TMPyP, 
Flexible cationic 
porphyrins 
-4logs, 10 µM,1min, 
2.2mW/cm2 365nm 
 
-6logs, 1min, 1µM, 
4.72mW/cm2 
nonenveloped ssRNA  
 
27-34nm, pI 3.9 21
 
Present 
study 
PRD-1 TMPyP, 
Flexible cationic 
porphyrins 
<1log, 30min, 1µM, 
4.72mW/cm2 
nonenveloped ds DNA  
 
63nm, pI 4.2  Present 
study 
Fungi 
 
Saprolegnia 
spp 
Fixed cationic 
Porphyrins, 
 
-2logs, 20min, 1µM, 
100mW/cm2 400-
800nm 
 
   
1
 
Candida 
albicans 
ATCC 18804 
Toluene blue, Rose 
Bengal bound to 
poly lysine 
 
-6 logs, 5µM, 
20j/cm2, 50-
400mW/cm2 
 
 Diploid  2
 
Yeast 
Saccharomyces 
cerevisiae 
Meso- arylglycosyl 
porphyrins 
 (TMPyP +sugar) 
3 logs, 10µM, 30 min, 
50mW/cm2 
 
   
26
 
102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parasites 
Acanthamoeba 
palestinensis 
Tetra cationic 
pthalocyanine 
1 log,  5min, 1 µM 
50mW/cm2, white 
Protozoa  15-35µm, oval 
or triangular 
when moving 
27
 
Ascaris 
lumbricoides 
Fixed porphyrin 
TMPyP tosyl 
48% , 30 min, 10 µM, 
0.005mW/cm2 
halogen 
 
nematode  Giant 
roundworm, 
eggs are 45-
75µm long 35-
50µm thick 
7
 
Taenia eggs Fixed porphyrin 
TMPyP 
20%, 30 min/10 µM, 
0.005mW/cm2 
halogen 
 
  Tapeworm 7
 
T. cruzi Phthalocyanines >4logs, 10min, 2µM euglenoid 
trypanosomes 
 Trypomastigote 28
 
P falciparum Phthalocyanines 92% inhibition, 
10min, 2µM 
Protozoa  Ring-stage 
Brazillian 
isolate 
28
 
Vahlkampfia 
hartmanni cysts 
 
Al(III)Phthalocyanine 
5 log, 10min, 3 µM, 
100mW/cm2 
 Protozoa   Fresh Water 
Amoeba, 
27
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Appendix 2. Additional 1H NMR and MS spectra of porphyrins before and 
after exposure to light 
In chapter 3 we synthesize the TBuPyP and the TProPyP.  Structures were 
confirmed with 1H NMR (shown below). These porphyrins showed no change in 
their 1H NMR spectra after 24 hours irradiation 
Figure A2.1 1H NMR of TProPyP before(a) and after (b) 24 hours of exposure to 
light. 
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Figure A2.2 1H NMR of TBuPyP before (a) and after (b) 24 hours of exposure to 
light 
 
(a) 
 
(b)
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Figures A2.3 through A2.6 show the mass spectra of the porphyrins before and 
after 24 hours exposure to light 
 
Figure A2.3 The mass spectra of C3PyP (a) and its photoproduct (b) 
(a)  
 (b) 
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Figure A2.4 The mass spectra of C4PyP (a) and its photoproduct (b) 
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Figure A2.5 The mass spectra of the TProPyP before (a) and after (b) 24 hours 
of exposure to light 
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(b) 
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Figure A2.6 The mass spectra of the TBuPyP before (a) and after (b) 24 hours 
of exposure to light 
 
(a) 
 
 
(b) 
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Appendix 3. Sample calculations for loss of water during the stability 
experiment in Chapter 3 
Sample calculations for one experiment are shown with a starting volume 
of 4.88mL of C4PyP and 4.45mL of TBuPyP after the t=0 sample.  The volume 
lost to evaporation at any time is the difference between the mass after a sample 
for the previous sample time and the mass before the sample of the current 
sampling time.  This mass in mg translates to the volume in mL loss to 
evaporation.  The after sample volume at a given time is the after sample volume 
from the previous sample time minus .210mL – (loss of evaporation).  (See Table 
A3.1) 
Table A3.1 The data collected in order to account for water evaporation in the 
formation of porphyrin products 
 
Time Before Sample Mass mg After Sample mass mg After sample volume mL 
 C4PyP TBuPyP C4PyP TBuPyP C4PyP TBuPyP 
0 19.6265 19.7836 19.2427 19.5419 4.88 4.4462 
1 19.2038 19.5018 18.9701 19.2638 4.6229 4.1973 
2 18.9386 19.2195 18.6989 18.9840 4.3756 3.9558 
4 18.6485 18.9275 18.4194 18.6903 4.1091 3.6954 
6 18.3651 18.6369 18.1325 18.4056 3.8448 3.4320 
24 17.8023 18.0143 17.5757 17.7892 3.2435 2.8918 
 
Concentration of test sample (t) = (Conc)t-1(volumeafter sample)t-1/(volumenew) 
 Where the new volume = (volumeafter sample)t-1 – ( volumeevaporation) 
At T=1 hour for C4PyP, the loss of water due to evaporation is as follows:  
110 
 
(Mass of to After sample)-(Mass of t1 Before Sample) = 19.2427-19.2038 = 
0.0389 
So, the concentration of the C4PyP test solution after one hour of evaporation is  
 (1mM)(4.88mL)/4.8411mL) = 1.008mM   
This sample would then be diluted with 1008µL to achieve the 10µM solution for 
the absorbance measurement.  Furthermore 1.008 mM will be used to calculate 
the concentration of the solution at the next sampling time. 
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Appendix 4. Actual values from porphyrin binding in Chapter 4 
From the E. coli and Salmonella binding experiments, the average data for 
each of the porphyrins was compared and only that of the TProPyP, which 
showed no measurable binding to either bacterium, was found to be significantly 
different from the other porphyrins. Data was analyzed using a paired 2 sided t- 
test using 0.05 as the lower limit for rejection of the null hypothesis (Table A4.1)  
Table A4.1 The paired t-test values for each porphyrin*  
 
 
 
 
 
*The E. coli results are shown in green (top right) and the Salmonella results are shown in 
blue(bottom left) 
 
In Chapter 4, the data from the porphyrin binding to MS2 and PRD-1, 
measured as the percent of porphyrin fluorescence, was presented as bar 
graphs. Table A4.2 shows the actual values that were used to produce those 
graphs. 
 
 
 
 
 
 
 
 
 
 
 
 
Porphyrin C3PyP C4PyP TProPyP TBuPyP 
C3PyP N/A 0.24 <0.01 <0.01 
C4PyP 0.36 N/A 0.03 0.51 
TProPyP <0.01 <0.01 N/A <0.01 
TBuPyP 0.85 0.73 0.02 N/A 
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Table A4.2 The binding to MS2 and PRD-1 measured as percent fluorescence 
when compared to controls* 
 
Sample C3PyP 
% (std dev) 
C4PyP 
% (std dev) 
TProPyP 
% (std dev) 
TBuPyP 
% (std dev) 
MS2 SN 85.8 (5.41) 88.4(7.96) 65.9(2.84) 63.3(4.22) 
MS2 Pellet 16.5 (4.11) 17.2(2.45) 17.2(3.42) 8.44(2.26) 
PRD-1 SN 87.2(3.64) 89.3(14.1) 69.3(4.22) 61.6(5.04) 
PRD-1 Pellet 20.0(4.31) 22.3(5.22) 16.3(3.16 15.4(2.18) 
Control SN 95.5(1.68) 94.6(2.16) 95.6(0.334) 100.6(1.98) 
Control pellet 2.54(0.610) 1.29(1.05) 3.02(2.00) 2.26(0.417) 
 
*Fluorecence was measured in the supernatant (SN) and resuspended pellet. Porphyrins (1 µM) 
and phage (~1010 pfu/mL) were centrifuged at 35000 g for 3 hours, supernatant was analyzed for 
fluorescence and compared to control samples with porphyrin and TSB. The above is an average 
of three trials done in duplicate. On average, 99.16 % (stdev 0.3695) of PRD-1 and 96.3 % (4.33) 
of MS2 was pelleted. 
 
As a control, to ensure that the bacteriophages were pelleted, viral stocks 
were plated before ultracentrifugation and after resuspension in equal volume to 
measure the percentage of virus pelletted by our methods (35000 g for 3 hours).  
We found that on average, 99.16 % (stdev 0.3695) of PRD-1 and 96.3 % (4.33) 
of MS2 was pelleted. 
In Chapter 4, there was not a complete recovery of the TProPyP or 
TBuPyP from analysis of the supernatant and resuspended pellet.  It was 
suggested that the porphyrin fluorescence was reduced by aggregation.  In 
previous degradation experiments TMPyP, a fixed cationic porphyrin similar to 
TProPyP and TBuPyP, showed an initial increase in absorbance when exposed 
to light.  This increase was thought to be from the disaggregation of porphyrin 
molecules via the generation of singlet oxygen. (See Figure 4A.1) A similar initial 
increase in the Soret was also observed for the TProPyP and the TBuPyP 
porphyrins (See Figure A4.2) 
 
 Figure A4.1The increase in the absorbance of the Soret of TMPyP over time
 
 
 
*Measurements were taken at various times of irradiation up to 24 hrs and diluted to 10 µM prior 
to analysis. 
Figure A4.2 The absorbance of the Soret of the TProPyP and T
porphyrins over time 
*Measurements were taken at various times of irradiation up to 24 hrs and diluted to 10 µM prior 
to analysis. 
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 Appendix 5. A sample HPLC chromatogram from measurements of singlet 
oxygen production in Chapter 4
  In Chapter 4 the singlet oxygen production of each porphyrin was 
measured using an HPLC and UV detector.  
 
Figure A5.1 A sample chromatogram of the porphyrin, photoproduct, furfuryl 
alcohol (FFA), and the internal standard 
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Appendix 6. Evidence of linear inactivation 
In Chapter 5, an assumption was made of a linear inactivation of the test 
pathogens over the time period of irradiation.  This assumption was based on the 
following graph, which shows that the inactivation of E. coli and Salmonella by 
C3 PyP and C4PyP fit well to the linear models.  The model for each porphyrin 
/combination is shown to the right of its description in the legend. 
 
Figure A6.1 Graphs showing linear inactivation of E. coli and Salmonella by 
C3PyP and C4PyP 
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